An	O
intricate	O
arrangement	O
of	O
binding	O
sites	O
for	O
the	O
Ets	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
regulates	O
activity	O
of	O
the	O
alpha	B-DNA
4	I-DNA
integrin	I-DNA
gene	I-DNA
promoter	I-DNA
.	O

alpha	B-protein
4	I-protein
integrins	I-protein
mediate	O
cell-cell	O
and	O
cell-extracellular	O
matrix	O
interactions	O
that	O
are	O
critical	O
for	O
maturation	O
and	O
function	O
of	O
the	O
immune	O
system	O
as	O
well	O
as	O
differentiation	O
of	O
skeletal	O
muscle	O
.	O

Here	O
we	O
examine	O
molecular	O
mechanisms	O
controlling	O
the	O
pattern	O
of	O
alpha	B-protein
4	I-protein
expression	O
.	O

The	O
activity	O
of	O
constructs	O
containing	O
5	B-DNA
'	I-DNA
deletion	I-DNA
mutants	I-DNA
of	O
the	O
alpha	B-DNA
4	I-DNA
gene	I-DNA
promoter	I-DNA
was	O
compared	O
in	O
transfection	O
assays	O
into	O
cell	B-cell_line
lines	I-cell_line
that	O
express	O
alpha	B-protein
4	I-protein
and	O
cell	B-cell_line
lines	I-cell_line
that	O
do	O
not	O
.	O

The	O
sequence	O
between	O
position	O
-42	B-DNA
and	I-DNA
-76	I-DNA
base	I-DNA
pairs	I-DNA
(	O
bp	O
)	O
was	O
required	O
for	O
efficient	O
transcription	O
in	O
cells	O
that	O
express	O
alpha	B-protein
4	I-protein
,	O
but	O
it	O
showed	O
no	O
activity	O
in	O
HeLa	B-cell_line
cells	I-cell_line
,	O
which	O
do	O
not	O
express	O
alpha	B-protein
4	I-protein
.	O

Three	O
binding	B-DNA
sites	I-DNA
for	O
the	O
Ets	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
are	O
found	O
in	O
this	O
region	O
:	O
two	O
adjacent	O
sites	O
at	O
positions	O
-50	B-DNA
and	I-DNA
-54	I-DNA
bp	I-DNA
and	O
a	O
more	O
5	B-DNA
'	I-DNA
site	I-DNA
at	O
position	O
-67	B-DNA
bp	I-DNA
.	O

Using	O
a	O
series	O
of	O
constructs	O
containing	O
deletions	O
and	O
mutations	O
in	O
this	O
region	O
,	O
we	O
found	O
that	O
the	O
3'-most	B-DNA
site	I-DNA
alone	O
was	O
sufficient	O
for	O
binding	O
GA-binding	B-protein
protein	I-protein
alpha	I-protein
(	O
GABP	B-protein
alpha	I-protein
)	I-protein
/GABP	I-protein
beta	I-protein
and	O
for	O
a	O
low	O
level	O
of	O
transcriptional	O
activation	O
.	O

When	O
all	O
three	O
sites	O
were	O
present	O
,	O
a	O
second	O
complex	O
``	O
a	O
''	O
was	O
detected	O
,	O
which	O
contains	O
an	O
unknown	O
member	O
of	O
the	O
Ets	B-protein
family	I-protein
.	O

Formation	O
of	O
complex	O
a	O
was	O
cell-type	O
specific	O
and	O
correlated	O
with	O
a	O
high	O
level	O
of	O
transcription	O
.	O

Deletion	O
of	O
the	O
5'-most	B-DNA
Ets	I-DNA
site	I-DNA
had	O
no	O
effect	O
on	O
binding	O
to	O
GABP	B-protein
alpha/GABP	I-protein
beta	I-protein
,	O
but	O
it	O
eliminated	O
a	O
.	O

Concomitant	O
with	O
this	O
loss	O
of	O
a	O
,	O
a	O
new	B-protein
Ets-1-containing	I-protein
complex	I-protein
``	O
c	B-protein
``	O
appeared	O
.	O

Complex	O
c	O
substituted	O
efficiently	O
for	O
complex	O
a	O
in	O
transcriptional	O
activation	O
.	O

We	O
conclude	O
that	O
although	O
neither	O
of	O
the	O
two	O
5'-most	B-DNA
Ets	I-DNA
sites	I-DNA
alone	O
binds	O
nuclear	B-protein
protein	I-protein
,	O
they	O
appear	O
to	O
act	O
as	O
modulators	O
which	O
control	O
the	O
pattern	O
of	O
Ets	B-protein
proteins	I-protein
that	O
bind	O
the	O
alpha	B-DNA
4	I-DNA
gene	I-DNA
promoter	I-DNA
.	O

This	O
arrangement	O
of	O
Ets	B-DNA
sites	I-DNA
,	O
coupled	O
with	O
the	O
tissue-	O
and	O
developmental-specific	O
expression	O
of	O
Ets	B-protein
members	I-protein
,	O
likely	O
play	O
a	O
key	O
role	O
in	O
defining	O
the	O
pattern	O
of	O
alpha	B-protein
4	I-protein
integrin	I-protein
.	O

Tir	NULL
Journat	NULL
or	NULL
Broroaicar	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

22	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
3	NULL
,	NULL
pp	NULL
.	NULL

15652-15660	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
An	NULL
Intricate	NULL
Arrangement	NULL
of	NULL
Binding	NULL
Sites	NULL
for	NULL
the	NULL
Ets	NULL
Family	NULL
of	NULL
Transcription	NULL
Factors	NULL
Regulates	NULL
Activity	NULL
of	NULL
the	NULL
«	NULL
4	NULL
Integrin	NULL
Gene	NULL
Promoter*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
November	NULL
30	NULL
,	NULL
1993	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
3	NULL
,	NULL
1994	NULL
)	NULL
Glenn	NULL
D.	NULL
Rosent§	NULL
,	NULL
Jennifer	NULL
L.	NULL
Barks	NULL
}	NULL
,	NULL
Michael	NULL
F.	NULL
Iademarcoj	NULL
}	NULL
1	NULL
,	NULL
Robert	NULL
J.	NULL
Fisher|	NULL
,	NULL
and	NULL
Douglas	NULL
C.	NULL
Deant**	NULL
From	NULL
the	NULL
{	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
and	NULL
the	NULL
|Program	NULL
Resources	NULL
Inc./DynCorp	NULL
,	NULL
Frederick	NULL
,	NULL
Maryland	NULL
21701	NULL
o4	NULL
integrins	NULL
mediate	NULL
cell-cell	NULL
and	NULL
cell-extracellular	NULL
matrix	NULL
interactions	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
maturation	NULL
and	NULL
function	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
as	NULL
well	NULL
as	NULL
differentiation	NULL
of	NULL
skeletal	NULL
muscle	NULL
.	NULL

Here	NULL
we	NULL
examine	NULL
molecular	NULL
mechanisms	NULL
controlling	NULL
the	NULL
pattern	NULL
of	NULL
«	NULL
4	NULL
expression	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
constructs	NULL
containing	NULL
5	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
a4	NULL
gene	NULL
promoter	NULL
was	NULL
compared	NULL
in	NULL
transfection	NULL
assays	NULL
into	NULL
cell	NULL
lines	NULL
that	NULL
express	NULL
a4	NULL
and	NULL
cell	NULL
lines	NULL
that	NULL
do	NULL
not	NULL
.	NULL

The	NULL
sequence	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
base	NULL
pairs	NULL
(	NULL
bp	NULL
)	NULL
was	NULL
required	NULL
for	NULL
efficient	NULL
transcription	NULL
in	NULL
cells	NULL
that	NULL
express	NULL
a4	NULL
,	NULL
but	NULL
it	NULL
showed	NULL
no	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
express	NULL
«	NULL
4	NULL
.	NULL

Three	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
found	NULL
in	NULL
this	NULL
region	NULL
:	NULL
two	NULL
adjacent	NULL
sites	NULL
at	NULL
positions	NULL
-50	NULL
and	NULL
-54	NULL
bp	NULL
and	NULL
a	NULL
more	NULL
5	NULL
'	NULL
site	NULL
at	NULL
position	NULL
-67	NULL
bp	NULL
.	NULL

Using	NULL
a	NULL
series	NULL
of	NULL
constructs	NULL
containing	NULL
deletions	NULL
and	NULL
mutations	NULL
in	NULL
this	NULL
re-gion	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
3'-most	NULL
site	NULL
alone	NULL
was	NULL
sufficient	NULL
for	NULL
binding	NULL
GA-binding	NULL
protein	NULL
«	NULL
(	NULL
GABP	NULL
«	NULL
)	NULL
/GABPG	NULL
and	NULL
for	NULL
a	NULL
low	NULL
level	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

When	NULL
all	NULL
three	NULL
sites	NULL
were	NULL
present	NULL
,	NULL
a	NULL
second	NULL
complex	NULL
``	NULL
a	NULL
``	NULL
was	NULL
de-tected	NULL
,	NULL
which	NULL
contains	NULL
an	NULL
unknown	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
.	NULL

Formation	NULL
of	NULL
complex	NULL
a	NULL
was	NULL
cell-type	NULL
specific	NULL
and	NULL
correlated	NULL
with	NULL
a	NULL
high	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
binding	NULL
to	NULL
GABPa	NULL
«	NULL
/GABPB	NULL
,	NULL
but	NULL
it	NULL
eliminated	NULL
a.	NULL
Concomitant	NULL
with	NULL
this	NULL
loss	NULL
of	NULL
a	NULL
,	NULL
a	NULL
new	NULL
Ets-l-containing	NULL
complex	NULL
``	NULL
c	NULL
``	NULL
ap-peared	NULL
.	NULL

Complex	NULL
c	NULL
substituted	NULL
efficiently	NULL
for	NULL
complex	NULL
a	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
although	NULL
neither	NULL
of	NULL
the	NULL
two	NULL
5'-most	NULL
Ets	NULL
sites	NULL
alone	NULL
binds	NULL
nuclear	NULL
protein	NULL
,	NULL
they	NULL
appear	NULL
to	NULL
act	NULL
as	NULL
modulators	NULL
which	NULL
control	NULL
the	NULL
pattern	NULL
of	NULL
Ets	NULL
proteins	NULL
that	NULL
bind	NULL
the	NULL
a4	NULL
gene	NULL
promoter	NULL
.	NULL

This	NULL
arrangement	NULL
of	NULL
Ets	NULL
sites	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
tissue-	NULL
and	NULL
developmental-specific	NULL
expression	NULL
of	NULL
Ets	NULL
members	NULL
,	NULL
likely	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
defining	NULL
the	NULL
pattern	NULL
of	NULL
a4	NULL
integrin	NULL
.	NULL

a4B1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
integrin	NULL
family	NULL
that	NULL
mediates	NULL
both	NULL
cell-extracellular	NULL
matrix	NULL
and	NULL
cell-cell	NULL
interactions	NULL
(	NULL
reviewed	NULL
in	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
AR41908	NULL
and	NULL
HL	NULL
43418	NULL
and	NULL
by	NULL
a	NULL
Career	NULL
Investigator	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Lung	NULL
Association	NULL
(	NULL
to	NULL
D.	NULL
C.	NULL
D.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Supported	NULL
by	NULL
Clinical	NULL
Investigator	NULL
Award	NULL
HI	NULL
02558	NULL
.	NULL

Present	NULL
ad-dress	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
94805	NULL
.	NULL

1	NULL
Supported	NULL
by	NULL
Training	NULL
Grant	NULL
HL	NULL
07317	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Box	NULL
8052	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
660	NULL
S.	NULL
Euclid	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110-1093	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
314-362-8989	NULL
;	NULL
Fax	NULL
:	NULL
314-362-8987	NULL
;	NULL
E-mail	NULL
:	NULL
Dean-	NULL
@	NULL
telesphere	NULL
.	NULL

wustl.edu	NULL
.	NULL

Hemler	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

For	NULL
cell-extracellular	NULL
matrix	NULL
interactions	NULL
,	NULL
«	NULL
4681	NULL
binds	NULL
to	NULL
the	NULL
CS1	NULL
domain	NULL
of	NULL
the	NULL
extracellular	NULL
matrix	NULL
protein	NULL
,	NULL
fibronectin	NULL
(	NULL
Wayner	NULL
,	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Guan	NULL
and	NULL
Hynes	NULL
,	NULL
1990	NULL
;	NULL
Mould	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
fibronectin	NULL
is	NULL
up-regulated	NULL
in	NULL
inflammation	NULL
and	NULL
tissue	NULL
injury	NULL
(	NULL
Macarak	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Lazenby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Walle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Kang	NULL
and	NULL
Williams	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
interaction	NULL
between	NULL
«	NULL
481	NULL
,	NULL
which	NULL
is	NULL
present	NULL
on	NULL
T-cells	NULL
,	NULL
B-cells	NULL
,	NULL
monocytes	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
eosi-nophils	NULL
(	NULL
reviewed	NULL
in	NULL
Hemler	NULL
(	NULL
1990	NULL
)	NULL
)	NULL
with	NULL
fibronectin	NULL
may	NULL
be	NULL
important	NULL
for	NULL
targeting	NULL
these	NULL
cells	NULL
to	NULL
sites	NULL
of	NULL
inflammation	NULL
and	NULL
injury	NULL
.	NULL

For	NULL
cell-cell	NULL
interactions	NULL
,	NULL
«	NULL
481	NULL
binds	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
,	NULL
'	NULL
which	NULL
appears	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
endothelial	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
inflammation	NULL
(	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Elices	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
of	NULL
«	NULL
461	NULL
on	NULL
immune	NULL
cells	NULL
with	NULL
VCAM-1	NULL
on	NULL
endothelial	NULL
cells	NULL
then	NULL
targets	NULL
immune	NULL
cells	NULL
to	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

The	NULL
a4B1-VCAM-1-me-diated	NULL
recruitment	NULL
of	NULL
immune	NULL
cells	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
in	NULL
diseases	NULL
such	NULL
as	NULL
asthma	NULL
(	NULL
Walsh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
arthritis	NULL
(	NULL
Laffon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
atherosclerosis	NULL
(	NULL
Cybulsky	NULL
and	NULL
Gimbrone	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
autoimmune	NULL
encephalompyelitis	NULL
(	NULL
Yednock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
B1	NULL
,	NULL
a4	NULL
can	NULL
associate	NULL
with	NULL
a	NULL
second	NULL
integrin	NULL
subunit	NULL
,	NULL
B7	NULL
(	NULL
Erle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Neuhaus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Yuan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruegg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

«	NULL
487	NULL
is	NULL
expressed	NULL
on	NULL
lymphoid	NULL
cells	NULL
,	NULL
and	NULL
recent	NULL
studies	NULL
show	NULL
that	NULL
«	NULL
487	NULL
binds	NULL
to	NULL
the	NULL
mucosal	NULL
vascular	NULL
addressin	NULL
,	NULL
MAdCAM-1	NULL
,	NULL
on	NULL
high	NULL
endothelial	NULL
cells	NULL
of	NULL
Peyer	NULL
's	NULL
patches	NULL
in	NULL
the	NULL
small	NULL
intestine	NULL
(	NULL
Berlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Briskin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
a48B7	NULL
and	NULL
MAd-CAM-1	NULL
is	NULL
thought	NULL
to	NULL
mediate	NULL
homing	NULL
of	NULL
lymphocytes	NULL
to	NULL
Peyer	NULL
's	NULL
patches	NULL
.	NULL

These	NULL
properties	NULL
described	NULL
above	NULL
suggest	NULL
a	NULL
key	NULL
role	NULL
for	NULL
o4	NULL
integrins	NULL
in	NULL
immune	NULL
function	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
a4	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
developmentally	NULL
regulated	NULL
pattern	NULL
in	NULL
several	NULL
developing	NULL
tissues	NULL
,	NULL
and	NULL
we	NULL
have	NULL
recently	NULL
demonstrated	NULL
a	NULL
role	NULL
for	NULL
«	NULL
481	NULL
and	NULL
VCAM-1	NULL
in	NULL
skeletal	NULL
muscle	NULL
differentiation	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
role	NULL
of	NULL
«	NULL
4	NULL
integrin	NULL
appears	NULL
to	NULL
extend	NULL
beyond	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

We	NULL
are	NULL
interested	NULL
in	NULL
molecular	NULL
events	NULL
controlling	NULL
the	NULL
pattern	NULL
of	NULL
a4	NULL
integrin	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
cloned	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
o4	NULL
gene	NULL
and	NULL
shown	NULL
that	NULL
it	NULL
acts	NULL
as	NULL
a	NULL
promoter	NULL
with	NULL
the	NULL
proper	NULL
cell	NULL
type	NULL
specificity	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Using	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
deletion	NULL
mutants	NULL
,	NULL
we	NULL
show	NULL
here	NULL
in	NULL
a	NULL
series	NULL
of	NULL
transfection	NULL
assays	NULL
that	NULL
a4	NULL
gene	NULL
expression	NULL
is	NULL
dependent	NULL
upon	NULL
binding	NULL
sites	NULL
for	NULL
Ets	NULL
transcription	NULL
factors	NULL
.	NULL

Ets	NULL
is	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
shares	NULL
a	NULL
conserved	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
Karim	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

They	NULL
bind	NULL
a	NULL
core	NULL
GGAA	NULL
motif	NULL
and	NULL
have	NULL
been	NULL
'	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
VCAM-1	NULL
,	NULL
vascular	NULL
cell	NULL
adhesion	NULL
mol-ecule-1	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
GABP	NULL
,	NULL
GA-binding	NULL
protein	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

15652	NULL
Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
several	NULL
promoters	NULL
,	NULL
including	NULL
Ick	NULL
(	NULL
Leung	NULL
,	NULL
1993	NULL
)	NULL
,	NULL
stromelysin	NULL
(	NULL
Wasylyk	NULL
,	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
collagen-ase	NULL
(	NULL
Gutman	NULL
and	NULL
Wasylyk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
cytochrome	NULL
c	NULL
oxidase	NULL
(	NULL
Carter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
the	NULL
Moloney	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
the	NULL
SV40	NULL
enhancer	NULL
(	NULL
Klemsz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type-1	NULL
and	NULL
-2	NULL
(	NULL
Bosselut	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Leiden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Ets-1	NULL
was	NULL
the	NULL
first	NULL
described	NULL
member	NULL
of	NULL
the	NULL
family	NULL
(	NULL
Gegonne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Watson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

It	NULL
was	NULL
originally	NULL
discovered	NULL
through	NULL
its	NULL
relationship	NULL
to	NULL
the	NULL
v-ets	NULL
transforming	NULL
oncogene	NULL
of	NULL
the	NULL
avian	NULL
retrovirus	NULL
E26	NULL
,	NULL
which	NULL
causes	NULL
leukemia	NULL
.	NULL

The	NULL
expanding	NULL
family	NULL
now	NULL
includes	NULL
Ets-2	NULL
(	NULL
Boulykos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
,	NULL
erg	NULL
(	NULL
Reddy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
,	NULL
elk-1	NULL
and	NULL
elk-2	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
spil/PU-1	NULL
(	NULL
Klemsz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
990	NULL
)	NULL
,	NULL
fli-1	NULL
(	NULL
Ben-David	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
elf-1	NULL
(	NULL
Leiden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
the	NULL
Drosophila	NULL
E74A	NULL
and	NULL
E74B	NULL
proteins	NULL
(	NULL
Burtis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
GA-binding	NULL
protein	NULL
(	NULL
GABP	NULL
)	NULL
(	NULL
LaMarco	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Although	NULL
they	NULL
recognize	NULL
a	NULL
common	NULL
core	NULL
of	NULL
GGAA	NULL
,	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
preferentially	NULL
bind	NULL
to	NULL
different	NULL
sites	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
specificity	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
sequence	NULL
flanking	NULL
the	NULL
GGAA	NULL
core	NULL
.	NULL

Ets	NULL
members	NULL
can	NULL
cooperate	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Ets-1	NULL
can	NULL
cooperate	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
to	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
polyoma	NULL
virus	NULL
enhancer	NULL
(	NULL
Wasylyk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Other	NULL
potentially	NULL
important	NULL
interactions	NULL
have	NULL
been	NULL
described	NULL
between	NULL
elk-1	NULL
and	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
Hipskind	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
E74	NULL
and	NULL
the	NULL
ecdysone	NULL
receptor	NULL
(	NULL
Koelle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
E74	NULL
and	NULL
E75	NULL
(	NULL
Feigl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Segraves	NULL
and	NULL
Hogness	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
PU.1	NULL
and	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
Hagemeier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
EIf-1	NULL
and	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
PU.1	NULL
and	NULL
TFIID	NULL
(	NULL
Hagemeier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
and	NULL
GABPa	NULL
and	NULL
GABPB	NULL
(	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Ankyrin	NULL
repeats	NULL
can	NULL
mediate	NULL
interactions	NULL
between	NULL
Ets	NULL
proteins	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

Studies	NULL
of	NULL
ankyrin	NULL
,	NULL
a	NULL
component	NULL
of	NULL
red	NULL
blood	NULL
cell	NULL
membranes	NULL
that	NULL
has	NULL
22	NULL
such	NULL
repeats	NULL
,	NULL
indicate	NULL
that	NULL
these	NULL
repeats	NULL
have	NULL
a	NULL
role	NULL
in	NULL
protein-proteins	NULL
interactions	NULL
(	NULL
Lux	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Recent	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
GABPa	NULL
interacts	NULL
with	NULL
the	NULL
33-amino	NULL
acid	NULL
ankyrin	NULL
repeats	NULL
of	NULL
forming	NULL
a	NULL
complex	NULL
that	NULL
contacts	NULL
DNA	NULL
more	NULL
stably	NULL
than	NULL
the	NULL
a	NULL
subunit	NULL
alone	NULL
(	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Ankyrin	NULL
repeats	NULL
have	NULL
also	NULL
been	NULL
found	NULL
in	NULL
other	NULL
regulatory	NULL
proteins	NULL
including	NULL
the	NULL
NF-	NULL
«	NULL
B/rel	NULL
family	NULL
(	NULL
Blank	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
Notch	NULL
in	NULL
Drosophila	NULL
,	NULL
and	NULL
glp-1	NULL
and	NULL
lin-12	NULL
in	NULL
Caenorh-abditis	NULL
elegans	NULL
(	NULL
Greenwald	NULL
,	NULL
1985	NULL
;	NULL
Wharton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Kidd	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Yochem	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Austin	NULL
and	NULL
Kimble	NULL
,	NULL
1989	NULL
;	NULL
Yochem	NULL
and	NULL
Greenwald	NULL
,	NULL
1989	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
motifs	NULL
could	NULL
also	NULL
be	NULL
important	NULL
for	NULL
mediating	NULL
interactions	NULL
between	NULL
other	NULL
sets	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
a4	NULL
gene	NULL
transcription	NULL
is	NULL
controlled	NULL
by	NULL
an	NULL
intricate	NULL
interaction	NULL
between	NULL
three	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

Using	NULL
a	NULL
series	NULL
of	NULL
deletions	NULL
and	NULL
point	NULL
mutations	NULL
,	NULL
we	NULL
characterize	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
sites	NULL
and	NULL
correlate	NULL
this	NULL
activity	NULL
to	NULL
the	NULL
interaction	NULL
with	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
and	NULL
DNA	NULL
Transfections-The	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
the	NULL
B-cell	NULL
line	NULL
,	NULL
Raji	NULL
,	NULL
were	NULL
maintained	NULL
in	NULL
Roswell	NULL
Park	NULL
Memorial	NULL
Institute	NULL
media	NULL
(	NULL
RPMI	NULL
)	NULL
(	NULL
1640	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
BTX	NULL
Transfector	NULL
300	NULL
(	NULL
BTX	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
described	NULL
(	NULL
Birkenmeier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Approximately	NULL
1	NULL
x	NULL
10	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
0.1	NULL
ml	NULL
of	NULL
RPMI	NULL
media	NULL
containing	NULL
HeBS	NULL
(	NULL
20	NULL
mx	NULL
Hepes	NULL
,	NULL
140	NULL
mm	NULL
NaC	NULL
)	NULL
,	NULL
5.0	NULL
my	NULL
KCl	NULL
,	NULL
0.7	NULL
myx	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
and	NULL
6.0	NULL
mm	NULL
dex-trose	NULL
)	NULL
,	NULL
salmon	NULL
sperm	NULL
DNA	NULL
at	NULL
1.25	NULL
ug/ml	NULL
,	NULL
and	NULL
30	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
and	NULL
subjected	NULL
to	NULL
electroporation	NULL
at	NULL
225	NULL
V	NULL
and	NULL
950	NULL
uF	NULL
.	NULL

The	NULL
rhabdomyosarcoma	NULL
cell	NULL
line	NULL
,	NULL
RD	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
transfected	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Dean	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Two	NULL
ug	NULL
of	NULL
pRSV/L	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
fused	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
(	NULL
de	NULL
Wet	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
,	NULL
was	NULL
included	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
in	NULL
transfection	NULL
assays	NULL
,	NULL
and	NULL
15653	NULL
equal	NULL
amounts	NULL
of	NULL
luciferase	NULL
activity	NULL
were	NULL
added	NULL
to	NULL
each	NULL
CAT	NULL
reaction	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
done	NULL
using	NULL
a	NULL
bioluminometer	NULL
(	NULL
Analytical	NULL
Biolu-minescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
described	NULL
(	NULL
de	NULL
Wet	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Thirty-six	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
protein	NULL
extracts	NULL
were	NULL
made	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Dean	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
with	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
contained	NULL
approximately	NULL
200	NULL
ug	NULL
of	NULL
protein	NULL
,	NULL
and	NULL
reactions	NULL
were	NULL
for	NULL
16	NULL
h.	NULL
Acetylation	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
was	NULL
quantified	NULL
by	NULL
thin	NULL
layer	NULL
chromatography	NULL
followed	NULL
by	NULL
scintillation	NULL
counting	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Plasmid	NULL
Construction-To	NULL
create	NULL
-2.0	NULL
a4CAT	NULL
,	NULL
the	NULL
«	NULL
4	NULL
genomic	NULL
clone	NULL
,	NULL
pa4-4.3	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
was	NULL
digested	NULL
with	NULL
Sail	NULL
(	NULL
position	NULL
-2003	NULL
bp	NULL
)	NULL
and	NULL
Nhel	NULL
(	NULL
position	NULL
~200	NULL
bp	NULL
)	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
fragment	NULL
was	NULL
li-gated	NULL
into	NULL
the	NULL
~400a4	NULL
CAT	NULL
construct	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
which	NULL
had	NULL
also	NULL
been	NULL
digested	NULL
with	NULL
Sall	NULL
and	NULL
NAeL	NULL
.	NULL

This	NULL
portion	NULL
of	NULL
the	NULL
a4	NULL
gene	NULL
5'-flanking	NULL
region	NULL
was	NULL
sequenced	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Both	NULL
strands	NULL
were	NULL
completely	NULL
sequenced	NULL
.	NULL

-2.004CAT	NULL
was	NULL
then	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
PCR	NULL
reactions	NULL
to	NULL
generate	NULL
a	NULL
series	NULL
of	NULL
5	NULL
'	NULL
deletion	NULL
mutants	NULL
in	NULL
the	NULL
a4	NULL
promoter	NULL
.	NULL

The	NULL
following	NULL
are	NULL
5	NULL
'	NULL
primers	NULL
used	NULL
for	NULL
each	NULL
construct	NULL
:	NULL
-1200a44CAT	NULL
(	NULL
5-CGATCTCGAGGGCTAAAACTTAAC-CCATCCA-3	NULL
'	NULL
)	NULL
,	NULL
1000a4CAT	NULL
(	NULL
5'-CGATCTCGAGGAGCTGAGCGAGA-CAAATTC-3	NULL
'	NULL
)	NULL
,	NULL
800a4CAT	NULL
(	NULL
5'-CGATCTCGAGATCTCTCTTTAAGTGT-TCCTTA-3	NULL
'	NULL
)	NULL
,	NULL
600a4CAT	NULL
(	NULL
5-CGATCTCGAGCTGTCATTAGTGTCAG-ATGTG-3	NULL
'	NULL
)	NULL
,	NULL
400a4CAT	NULL
(	NULL
5'-CGATCTCGAGAAGGCAGGGCACACCTG-GATTG-3	NULL
'	NULL
)	NULL
,	NULL
200a4CAT	NULL
(	NULL
5'-CGATCTCGAGCGTTAAATGTGAATCAAGT-CACAG-3	NULL
'	NULL
)	NULL
,	NULL
120a44CAT	NULL
-	NULL
(	NULL
5-CGATCTCGAGTCAGCCTGAGAGGCT	NULL
GCTGCT-3	NULL
'	NULL
)	NULL
,	NULL
76e4CAT	NULL
(	NULL
5'-CGATCTCGAGGCTGCAGAGGAAGTGTG-GGGAGG-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
42a44CAT	NULL
(	NULL
5'-CGATCTCGAGGTATAGAAGGGT-GCTGAGATGTGG-3	NULL
'	NULL
)	NULL
.	NULL

Numbers	NULL
in	NULL
the	NULL
construct	NULL
name	NULL
indicate	NULL
the	NULL
amount	NULL
of	NULL
5'-flanking	NULL
region	NULL
present	NULL
;	NULL
an	NULL
Xho	NULL
I	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
was	NULL
included	NULL
on	NULL
the	NULL
5	NULL
end	NULL
of	NULL
each	NULL
primer	NULL
for	NULL
cloning	NULL
purposes	NULL
.	NULL

A	NULL
common	NULL
3	NULL
'	NULL
primer	NULL
extending	NULL
to	NULL
position	NULL
+15	NULL
bp	NULL
and	NULL
containing	NULL
a	NULL
HindIII	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
on	NULL
its	NULL
5	NULL
'	NULL
end	NULL
was	NULL
used	NULL
in	NULL
each	NULL
PCR	NULL
reaction	NULL
(	NULL
5'-CAC-GAAGCTTGACAAAGACGT	NULL
TATGGCTATTC-3	NULL
'	NULL
)	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
Xhol	NULL
and	NULL
HindIII	NULL
and	NULL
cloned	NULL
into	NULL
pSKCAT-Pst/Bam	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
which	NULL
had	NULL
been	NULL
digested	NULL
with	NULL
the	NULL
same	NULL
enzymes	NULL
.	NULL

Constructs	NULL
were	NULL
sequenced	NULL
to	NULL
insure	NULL
that	NULL
errors	NULL
did	NULL
not	NULL
occur	NULL
during	NULL
PCR	NULL
.	NULL

Complementary	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
three	NULL
consensus	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
a4	NULL
gene	NULL
promoter	NULL
from	NULL
position	NULL
~42	NULL
to	NULL
-76	NULL
bp	NULL
(	NULL
5'-AGCTTGGCTGCAGAGGAAGTG	NULL
TGGGGAGGAAGGAAGT-GGGA-3	NULL
'	NULL
)	NULL
were	NULL
synthesized	NULL
such	NULL
that	NULL
after	NULL
annealing	NULL
,	NULL
HindIII	NULL
sites	NULL
are	NULL
present	NULL
on	NULL
each	NULL
end	NULL
.	NULL

Nucleotides	NULL
contributing	NULL
to	NULL
HindIII	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

Annealed	NULL
oligonucleotides	NULL
were	NULL
cloned	NULL
into	NULL
pTACAT	NULL
(	NULL
Weintraub	NULL
and	NULL
Dean	NULL
,	NULL
1992	NULL
)	NULL
,	NULL
a	NULL
minimal	NULL
promoter	NULL
construct	NULL
containing	NULL
the	NULL
SV40	NULL
early	NULL
gene	NULL
TATA	NULL
box	NULL
driving	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
which	NULL
had	NULL
been	NULL
digested	NULL
with	NULL
HindIII	NULL
to	NULL
create	NULL
pTA	NULL
(	NULL
-42/-76	NULL
)	NULL
CAT	NULL
;	NULL
the	NULL
HindIII	NULL
site	NULL
is	NULL
located	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
same	NULL
strategy	NULL
was	NULL
used	NULL
to	NULL
construct	NULL
plasmids	NULL
containing	NULL
only	NULL
the	NULL
two	NULL
3'-most	NULL
Ets	NULL
sites	NULL
at	NULL
positions	NULL
-54	NULL
and	NULL
-50	NULL
bp	NULL
in	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
(	NULL
5'-AGCTTGTGT-GGGGAGGAAGGAAGTGGGA-3	NULL
'	NULL
;	NULL
pTA	NULL
(	NULL
-42/-63	NULL
)	NULL
CAT	NULL
]	NULL
and	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-67	NULL
bp	NULL
[	NULL
5-AGCTTTGCAGAGGAAGTA-3	NULL
'	NULL
;	NULL
pTA	NULL
(	NULL
-62/	NULL
~73	NULL
)	NULL
CAT	NULL
]	NULL
.	NULL

Mutations	NULL
were	NULL
made	NULL
in	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
to	NULL
generate	NULL
mutant	NULL
I	NULL
(	NULL
M	NULL
I	NULL
)	NULL
(	NULL
5'-AGCTTGTGTGGGGAAGAAA-GAAGTGGGA-3	NULL
'	NULL
)	NULL
,	NULL
M	NULL
II	NULL
(	NULL
5-AGCTTGTGTGGGGAGGAAAGAAGTG-GGA-3	NULL
)	NULL
,	NULL
and	NULL
M	NULL
III	NULL
(	NULL
5'-AGCTT	NULL
GTGTGGGTATGAAGGAAGTGGGA-3	NULL
'	NULL
)	NULL
.	NULL

Mutated	NULL
nucleotides	NULL
are	NULL
in	NULL
bold	NULL
,	NULL
and	NULL
nucleotides	NULL
contributing	NULL
to	NULL
HindIII	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

Gel	NULL
Retardation	NULL
Assays-Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cell	NULL
lines	NULL
were	NULL
prepared	NULL
using	NULL
a	NULL
modified	NULL
Dig-nam	NULL
protocol	NULL
(	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
rinsed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

The	NULL
pelleted	NULL
cells	NULL
were	NULL
re-suspended	NULL
in	NULL
15	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Hepes	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
5	NULL
mm	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.25	NULL
m	NULL
sucrose	NULL
,	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
4	NULL
mm	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
,	NULL
and	NULL
10	NULL
mm	NULL
dithiothreitol	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
using	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
,	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
a	NULL
solution	NULL
of	NULL
20	NULL
mm	NULL
Hepes	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.35	NULL
KCl	NULL
,	NULL
0.1	NULL
my	NULL
EGTA	NULL
,	NULL
0.5	NULL
mym	NULL
EDTA	NULL
,	NULL
0.01	NULL
%	NULL
aprotinin	NULL
,	NULL
0.01	NULL
%	NULL
leupeptin	NULL
,	NULL
and	NULL
4	NULL
mm	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
.	NULL

Single-stranded	NULL
oligonucleotides	NULL
were	NULL
annealed	NULL
in	NULL
10	NULL
my	NULL
KCl	NULL
,	NULL
then	NULL
purified	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Gel-purified	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
labeled	NULL
on	NULL
their	NULL
5	NULL
'	NULL
ends	NULL
with	NULL
°P	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

For	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
nuclear	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
P-labeled	NULL
probe	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
100	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
albu-min	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
1	NULL
nl	NULL
of	NULL
anti-Ets	NULL
antibody	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
P-labeled	NULL
probe	NULL
in	NULL
the	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

When	NULL
antibodies	NULL
were	NULL
included	NULL
,	NULL
the	NULL
dithiothreitol	NULL
content	NULL
of	NULL
the	NULL
binding	NULL
buffer	NULL
was	NULL
reduced	NULL
to	NULL
15654	NULL
Human~-	NULL
++	NULL
ee	NULL
os	NULL
Mouse-	NULL
CCAGCAC	NULL
TTGCCTCCTG	NULL
CTCCAGCGT	NULL
o	NULL
6	NULL
s	NULL
e	NULL
a	NULL
e	NULL
e	NULL
ae	NULL
e	NULL
ese	NULL
ese	NULL
ce	NULL
es	NULL
se	NULL
+	NULL
e	NULL
66	NULL
ee	NULL
se	NULL
es	NULL
G	NULL
s	NULL
0	NULL
ee	NULL
e	NULL
ee	NULL
0	NULL
sesee	NULL
cee	NULL
«	NULL
ee	NULL
«	NULL
e	NULL
e	NULL
see	NULL
a	NULL
«	NULL
e	NULL
#	NULL
Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
TCGATCAGAG	NULL
AGATAGCAGT	NULL
ATCTTCAGTT	NULL
TTTTTTAAAG	NULL
CAACATGAAA	NULL
CACACTTTAT	NULL
TCCTGCTAAC	NULL
ATTAGGAAAA	NULL
GCGAGCTGTT	NULL
-1904	NULL
TTCCAAGCCC	NULL
TGGAGGAAGG	NULL
AAATTCAGCT	NULL
AACTAACGTG	NULL
AGGTAATGTA	NULL
GGGTGGCTAT	NULL
TTCTTGAAAG	NULL
GTAGTGAATC	NULL
ATAACTATAA	NULL
CCATACTATG	NULL
-1804	NULL
GAAAAAAGTC	NULL
CTGCCTTACC	NULL
AACCACTCCA	NULL
CTGACTGCTT	NULL
GTCACCAAAA	NULL
CTACGCTATG	NULL
AAACGAATTG	NULL
TGTTGAGTGG	NULL
CTTTCATTGT	NULL
AAAAGATTTT	NULL
-1704	NULL
GCTGAAGGGA	NULL
GGCAAAGAAA	NULL
CTGGTAGGGG	NULL
TTCAGATCAG	NULL
AAGATCTGGC	NULL
TTPGCCAGTPT	NULL
TCTGGAGGGT	NULL
GTCAGAATGG	NULL
CTTCAACATA	NULL
CCTACTTCCT	NULL
-1604	NULL
TGGCCTCAAC	NULL
TGGAGGTTTT	NULL
GTAGCTGTAA	NULL
ACAAGCAAGCA	NULL
TTGCATAGTT	NULL
CAGAATAACG	NULL
ACACTGTAAG	NULL
CTCATTGTGS	NULL
AACTGGGTTA	NULL
AAATCAGCAT	NULL
-1504	NULL
GTAGATCTAC	NULL
TAAGAAAGAA	NULL
ACACACTCAG	NULL
CACTACTACA	NULL
GAAAGAAACA	NULL
GCCATGGGCC	NULL
CTGATTGTTA	NULL
GCTTTCTGGA	NULL
AGCCATTTCA	NULL
TTTTTACAAT	NULL
-1404	NULL
AGATTTATCA	NULL
CACACTGTAT	NULL
TGACTTTTTC	NULL
CAGTATAGAG	NULL
TAAGAGAAAG	NULL
TTAATATTCC	NULL
TCATGTTTTG	NULL
TCTGTTGACA	NULL
GACTGAAAAT	NULL
AATTGCATTG	NULL
-1304	NULL
AGTTTGGCTA	NULL
GAATATCCTG	NULL
TCATTCCATA	NULL
AACATCTCAA	NULL
ACTCCACATG	NULL
GCTAAAACTT	NULL
AACCCATCCA	NULL
TGCCCCCATC	NULL
TGCATGCACA	NULL
CATACATGCA	NULL
-1204	NULL
TATAACTTCA	NULL
TTTCTCAGTG	NULL
TTTTTTTCTC	NULL
CATGAATGGT	NULL
AGCACCATTC	NULL
TCTTTCAAGA	NULL
AAGAGAAATA	NULL
CTTCCCCTTG	NULL
GGATTATCCT	NULL
ATCTCTACTT	NULL
-1104	NULL
ATTGCTGCAG	NULL
GGGCTTCCAA	NULL
AATTAGGTTT	NULL
TCTGTGTTCA	NULL
GTCTTGCATT	NULL
CACACTTCTG	NULL
AAACCCAGAG	NULL
CTGACCGAGA	NULL
CAAATTCTTC	NULL
AACTTCCTGT	NULL
-1004	NULL
CAGTCCCAAC	NULL
ATAGATTTAA	NULL
AATTCCTAAC	NULL
CTGGCTCATG	NULL
AGGTTCACCA	NULL
TGTATTCCTG	NULL
CTTCCCTAAG	NULL
TCAGCCTCAT	NULL
ATCACACCAA	NULL
CCTGTGTore	NULL
|	NULL
-904	NULL
GAGTGGCTAA	NULL
ATACTCTAGC	NULL
CAGGCAAGCT	NULL
CTCTCAGTTC	NULL
TTCTACCTGG	NULL
CTCCTCTGGA	NULL
GCCCTCCTTA	NULL
TTGCTCATCC	NULL
CATTCTTAGC	NULL
CTGATTCAAG	NULL
-	NULL
~804	NULL
ATTCCTGGTC	NULL
CTTCAAATCT	NULL
CTCTTTAAGT	NULL
GTCCTTACCT	NULL
GGATCTTTCT	NULL
CTAGTTAGTA	NULL
CAAATTTTTC	NULL
TATCTACCAT	NULL
TGGAGCGAAC	NULL
ATTTTTTGAA	NULL
|	NULL
-704	NULL
ACTTTGTATC	NULL
AGTCCTGCCT	NULL
TACTCTTGGT	NULL
GGAATCCTGT	NULL
GGTCCTAGTC	NULL
AAGTGCCTGC	NULL
TCCATGAATG	NULL
TGCTGAATAA	NULL
ATGAATAAGC	NULL
ATTTTAATTG	NULL
-	NULL
-604	NULL
TGTATCTGTC	NULL
ATTAGTGTCA	NULL
GATGTGTTAT	NULL
TTATTCCAGC	NULL
ATGGTTTTAG	NULL
CACACAGACA	NULL
CACTCTTTGA	NULL
TGCAGACTTT	NULL
TCTTTTCTTT	NULL
TTACATATAG	NULL
|	NULL
-504	NULL
CAACAATAAA	NULL
AAACTAG-AC	NULL
TT	NULL
--	NULL
-TCAT-	NULL
CTCC	NULL
--	NULL
-~-TG	NULL
AAAA-TA-TC	NULL
AGTCTAATAA	NULL
TCA-CCTATG	NULL
GC-TGTCTCT	NULL
CTGGT-TGCT	NULL
GAAGGAAAAA	NULL
|	NULL
-418	NULL
sees	NULL
we	NULL
even	NULL
oe	NULL
f	NULL
so	NULL
2k	NULL
k	NULL
ck	NULL
k	NULL
0	NULL
.	NULL

&	NULL
AAAAGCAGGG	NULL
AATGGAATAT	NULL
GGAGTGTAAG	NULL
ACATAAATTA	NULL
AAAATAAAAT	NULL
AAAATTAAAA	NULL
G	NULL
GCAGG	NULL
--	NULL
GCA	NULL
CACCTGGATT	NULL
GCATT-AGAA	NULL
TGAGACTCAC	NULL
TACCCAGTTC	NULL
AGGTGTGTTG	NULL
CGTTGTGGGT	NULL
CTCCGGC-Ac	NULL
ATTPCAGAGG	NULL
|	NULL
-322	NULL
paks	NULL
ver	NULL
o	NULL
ois	NULL
se	NULL
e	NULL
os	NULL
c	NULL
se	NULL
cs	NULL
vv	NULL
ses	NULL
se	NULL
n	NULL
Chek	NULL
eek	NULL
AAAAAAAAAG	NULL
AAAAGCAGCA	NULL
CACAAGGAGT	NULL
ATGTTCAGCA	NULL
-GAGGCCCAT	NULL
CTCCTGGCTT	NULL
AGGTGTGECTG	NULL
TGACTCTGAT	NULL
CTCTGGTGGc	NULL
TTTTTAGAAG	NULL
CTGATTAGGA	NULL
CCCTGACCCC	NULL
ACACTGGCGT	NULL
TTACACCCCT	NULL
AAAAGCAGGT	NULL
GTGTCCCGTG	NULL
GCAACTGAGT	NULL
GSGTGCGTGA	NULL
AAAGGGGGGA	NULL
-TCATCAATT	NULL
|	NULL
-223	NULL
&	NULL
a	NULL
sess	NULL
|	NULL
esses	NULL
a	NULL
e	NULL
e	NULL
cersssee	NULL
s	NULL
ee	NULL
a	NULL
ek	NULL
see	NULL
e	NULL
s	NULL
ex	NULL
ek	NULL
CCTGTTATGA	NULL
CCTTG-TCTT	NULL
AGGCT-GTGT	NULL
CTACACATCT	NULL
GGTGGTAGGT	NULL
ATGTCCTGGG	NULL
GTAACTGAGT	NULL
GTGTACATG-	NULL
--	NULL
-GGGACTA	NULL
GTTATGAAGA	NULL
A-CCAGCTGG	NULL
AGCAATCGAA	NULL
TCGGTTAAAT	NULL
GTGAATCAAG	NULL
TCACAGTGCT	NULL
TCCTTAACCC	NULL
AACCTCTCTG	NULL
TTGGGGTCAG	NULL
CCACAGCCTA	NULL
AMCCécetgc	NULL
|	NULL
-124	NULL
vo	NULL
e.	NULL
as	NULL
sess	NULL
steven	NULL
0	NULL
6	NULL
srsese	NULL
s	NULL
6.	NULL
aes	NULL
&	NULL
aes	NULL
AGTGAGC	NULL
--	NULL
A	NULL
AGGGGTGGAG	NULL
TCTGCTAA	NULL
--	NULL
GTGAGGCAAG	NULL
TCACAGAATT	NULL
TCCTTAGC	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
TTG	NULL
CCTéGqp	NULL
--	NULL
-	NULL
--	NULL
-~	NULL
--	NULL
-	NULL
Tp-	NULL
--	NULL
--	NULL
-	NULL
fore-TGGGTATAGA	NULL
AGGGTGctcA	NULL
-	NULL
-26	NULL
CGTTCAGCCT	NULL
GAGAGGCTGC	NULL
TGCTAGCCTG	NULL
CTCACGCATG	NULL
CaGCCcGocsc	NULL
TGcAcAGeAA	NULL
cror	NULL
--	NULL
cecse	NULL
a	NULL
0	NULL
ea	NULL
.	NULL

vas	NULL
+	NULL
«	NULL
*	NULL
0	NULL
0	NULL
6	NULL
so	NULL
e	NULL
Bood	NULL
*	NULL
s	NULL
o	NULL
e	NULL
aa	NULL
vv	NULL
ne	NULL
e	NULL
aa	NULL
6	NULL
60	NULL
e	NULL
68	NULL
se	NULL
8	NULL
ce	NULL
TGTT-AGGCT	NULL
--	NULL
-A	NULL
--	NULL
TTGC	NULL
--	NULL
CTSGCTTG	NULL
CTCATGCGTA	NULL
TAGACTCTAT	NULL
TTAAGAGGAA	NULL
GTGTATAGAG	NULL
AGGAAGGAAG	NULL
CCTGCATAAA	NULL
AGGCTGCAGG	NULL
+1	NULL
GATGTGGGTC	NULL
TTGAAGAGAA	NULL
TAGCCATA-A	NULL
CGTCT	NULL
ee	NULL
a	NULL
es	NULL
oa	NULL
cee	NULL
ce	NULL
a	NULL
0	NULL
se	NULL
ee	NULL
sees	NULL
6	NULL
e	NULL
6	NULL
00	NULL
CCTGGGAGTT	NULL
TTGAAGAGAC	NULL
TAGCCATATA	NULL
CTTTT	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
5	NULL
end	NULL
and	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
a4	NULL
genes	NULL
.	NULL

The	NULL
arrow	NULL
denotes	NULL
the	NULL
major	NULL
site	NULL
of	NULL
transcription	NULL
initiation	NULL
from	NULL
the	NULL
human	NULL
a4	NULL
gene	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
mouse	NULL
a4	NULL
gene	NULL
5'-flanking	NULL
region	NULL
was	NULL
obtained	NULL
from	NULL
De	NULL
Meirsman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
GenBank	NULL
accession	NULL
number	NULL
L20788	NULL
)	NULL
.	NULL

Sequences	NULL
were	NULL
aligned	NULL
using	NULL
the	NULL
Nucleic	NULL
Acid	NULL
and	NULL
Protein	NULL
Sequence	NULL
Program	NULL
from	NULL
Intelligenetics	NULL
Geneworks	NULL
.	NULL

The	NULL
three	NULL
boxed	NULL
Ets	NULL
sites	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
are	NULL
conserved	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
.	NULL

The	NULL
GenBank	NULL
accession	NULL
number	NULL
for	NULL
the	NULL
human	NULL
sequence	NULL
is	NULL
L26059	NULL
.	NULL

1	NULL
mm	NULL
,	NULL
which	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
assays	NULL
.	NULL

The	NULL
anti-Ets-1	NULL
antibody	NULL
(	NULL
E44	NULL
)	NULL
is	NULL
a	NULL
monoclonal	NULL
generated	NULL
against	NULL
the	NULL
bacterially	NULL
expressed	NULL
v-Ets	NULL
protein	NULL
(	NULL
Koisumi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Pan	NULL
Ets	NULL
is	NULL
a	NULL
monoclonal	NULL
antibody	NULL
generated	NULL
against	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
Ets	NULL
gene	NULL
family	NULL
(	NULL
Bhat	NULL
and	NULL
Papas	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Anti-Ets-2	NULL
(	NULL
U244	NULL
)	NULL
is	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
Ets-2	NULL
(	NULL
Fu-jiwara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Anti-GABPa	NULL
and	NULL
anti-GABPS	NULL
antibodies	NULL
and	NULL
bacterial	NULL
expressed	NULL
purified	NULL
GABPa	NULL
and	NULL
GABPB	NULL
have	NULL
been	NULL
described	NULL
(	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
Ets	NULL
site	NULL
from	NULL
the	NULL
Moloney	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
is	NULL
5-GCGCGCTTCCGCTCTCCGAG-3	NULL
'	NULL
(	NULL
Gunther	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Ets	NULL
site	NULL
from	NULL
SV40	NULL
is	NULL
5'-~TAACCTCTGAAAGAG-GAACTT-3	NULL
'	NULL
(	NULL
Pettersson	NULL
and	NULL
Schaffner	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

RESULTS	NULL
The	NULL
Region	NULL
between	NULL
Position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
of	NULL
the	NULL
«	NULL
4	NULL
Gene	NULL
Is	NULL
Required	NULL
for	NULL
Efficient	NULL
Transcription-We	NULL
have	NULL
reported	NULL
previously	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
a4	NULL
gene	NULL
5'-flanking	NULL
sequence	NULL
to	NULL
position	NULL
-423	NULL
bp	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

1	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
5'-flanking	NULL
region	NULL
to	NULL
position	NULL
-1993	NULL
bp	NULL
is	NULL
presented	NULL
and	NULL
a	NULL
portion	NULL
of	NULL
this	NULL
sequence	NULL
is	NULL
compared	NULL
with	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
mouse	NULL
a4	NULL
gene	NULL
5'-flanking	NULL
region	NULL
.	NULL

This	NULL
comparison	NULL
reveals	NULL
a	NULL
significant	NULL
conservation	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
between	NULL
human	NULL
and	NULL
mouse	NULL
.	NULL

A	NULL
series	NULL
of	NULL
5	NULL
deletions	NULL
were	NULL
created	NULL
in	NULL
the	NULL
human	NULL
a4	NULL
gene	NULL
promoter	NULL
to	NULL
determine	NULL
which	NULL
regions	NULL
are	NULL
important	NULL
for	NULL
expression	NULL
.	NULL

The	NULL
resulting	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
which	NULL
expresses	NULL
«	NULL
4	NULL
,	NULL
and	NULL
the	NULL
HeLa	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
does	NULL
not	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
«	NULL
4	NULL
promoter	NULL
was	NULL
active	NULL
in	NULL
the	NULL
Jurkat	NULL
,	NULL
but	NULL
not	NULL
the	NULL
Hela	NULL
,	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Little	NULL
change	NULL
in	NULL
promoter	NULL
activity	NULL
was	NULL
seen	NULL
with	NULL
sequential	NULL
deletions	NULL
from	NULL
position	NULL
-2.0	NULL
kilobase	NULL
to	NULL
position	NULL
-400	NULL
bp	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Deletion	NULL
from	NULL
position	NULL
-400	NULL
to	NULL
~76	NULL
bp	NULL
caused	NULL
an	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
negative	NULL
element	NULL
is	NULL
removed	NULL
with	NULL
this	NULL
dele-tion	NULL
.	NULL

However	NULL
,	NULL
a	NULL
subsequent	NULL
deletion	NULL
from	NULL
position	NULL
-76	NULL
to	NULL
~42	NULL
bp	NULL
,	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
,	NULL
severely	NULL
inhibited	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
elements	NULL
required	NULL
for	NULL
transcription	NULL
of	NULL
the	NULL
a4	NULL
gene	NULL
are	NULL
located	NULL
in	NULL
this	NULL
region	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
when	NULL
these	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
other	NULL
cell	NULL
lines	NULL
that	NULL
express	NULL
«	NULL
4	NULL
,	NULL
such	NULL
as	NULL
the	NULL
B-cell	NULL
line	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
the	NULL
rhabdomyosarcoma	NULL
cell	NULL
line	NULL
,	NULL
RD	NULL
(	NULL
Wayner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Hemler	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

This	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
is	NULL
highly	NULL
conserved	NULL
from	NULL
human	NULL
to	NULL
mouse	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
Region	NULL
between	NULL
Position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
Can	NULL
Activate	NULL
a	NULL
Heterologous	NULL
Promoter-To	NULL
determine	NULL
whether	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
was	NULL
sufficient	NULL
to	NULL
activate	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
it	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
minimal	NULL
promoter	NULL
construct	NULL
,	NULL
pTACAT	NULL
,	NULL
which	NULL
contains	NULL
only	NULL
the	NULL
SV40	NULL
early	NULL
gene	NULL
TATA	NULL
box	NULL
driving	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Weintraub	NULL
and	NULL
Dean	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
transfection	NULL
assays	NULL
into	NULL
Jurkat	NULL
cells	NULL
,	NULL
this	NULL
region	NULL
significantly	NULL
stimulated	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
seen	NULL
when	NULL
this	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
Raji	NULL
and	NULL
RD	NULL
cell	NULL
lines	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
is	NULL
critical	NULL
for	NULL
transcription	NULL
of	NULL
the	NULL
a4	NULL
gene	NULL
,	NULL
and	NULL
it	NULL
is	NULL
sufficient	NULL
to	NULL
stimulate	NULL
activity	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

The	NULL
Region	NULL
between	NULL
Position	NULL
-42	NULL
and	NULL
~76	NULL
bp	NULL
Contains	NULL
Binding	NULL
Sites	NULL
for	NULL
Ets	NULL
Transcription	NULL
Factors-A	NULL
survey	NULL
of	NULL
the	NULL
sequence	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
revealed	NULL
three	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
:	NULL
two	NULL
adjacent	NULL
sites	NULL
at	NULL
positions	NULL
-50	NULL
and	NULL
-54	NULL
bp	NULL
and	NULL
a	NULL
third	NULL
site	NULL
at	NULL
position	NULL
-67	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
sites	NULL
is	NULL
conserved	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
.	NULL

Binding	NULL
of	NULL
proteins	NULL
to	NULL
this	NULL
region	NULL
was	NULL
examined	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

Two	NULL
complexes	NULL
were	NULL
observed	NULL
:	NULL
one	NULL
appeared	NULL
as	NULL
a	NULL
broad	NULL
band	NULL
,	NULL
designated	NULL
``	NULL
a	NULL
,	NULL
``	NULL
and	NULL
the	NULL
other	NULL
as	NULL
a	NULL
more	NULL
compact	NULL
rapidly	NULL
migrating	NULL
band	NULL
,	NULL
designated	NULL
``	NULL
b	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Occasionally	NULL
,	NULL
additional	NULL
more	NULL
rapidly	NULL
migrating	NULL
bands	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
gel	NULL
retar-	NULL
Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
15655	NULL
Jurkat	NULL
HeLa	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
5	NULL
'	NULL
deletions	NULL
on	NULL
hu-	NULL
100	NULL
-|	NULL
|	NULL
man	NULL
a4	NULL
promoter	NULL
activity	NULL
.	NULL

Constructs	NULL
containing	NULL
different	NULL
amounts	NULL
of	NULL
«	NULL
4	NULL
gene	NULL
5'-flanking	NULL
region	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cell	NULL
lines	NULL
.	NULL

Numbers	NULL
in	NULL
the	NULL
construct	NULL
name	NULL
indicate	NULL
the	NULL
length	NULL
of	NULL
4	NULL
gene	NULL
5'-flanking	NULL
region	NULL
.	NULL

Constructs	NULL
are	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
.	NULL
``	NULL

SKCAT-Pst/Bam	NULL
is	NULL
the	NULL
parent	NULL
vector	NULL
and	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
promoter	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
pSVCAT	NULL
is	NULL
a	NULL
control	NULL
vector	NULL
containing	NULL
the	NULL
SV40	NULL
early	NULL
gene	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

Results	NULL
are	NULL
an	NULL
average	NULL
of	NULL
duplicate	NULL
assays	NULL
from	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

100	NULL
%	NULL
relative	NULL
activity	NULL
corresponds	NULL
to	NULL
51	NULL
%	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
to	NULL
acetylated	NULL
forms	NULL
in	NULL
Jurkats	NULL
and	NULL
60	NULL
%	NULL
conversion	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

75-	NULL
25	NULL
Relative	NULL
CAT	NULL
Activity	NULL
0—	NULL
¥	NULL
eq	NULL
’	NULL
o	NULL
Q	NULL
’	NULL
o	NULL
7	NULL
,	NULL
7	NULL
A	NULL
.	NULL

Probe	NULL
1007	NULL
Competitor	NULL
75-I	NULL
50	NULL
Relative	NULL
CAT	NULL
Activity	NULL
25-1	NULL
i	NULL
2	NULL
*n	NULL
*n	NULL
*~	NULL
~42/-76	NULL
«	NULL
b	NULL
&	NULL
6°	NULL
a	NULL
``	NULL
s	NULL
l	NULL
...	NULL
,	NULL
b	NULL
to	NULL
%	NULL
49	NULL
Q	NULL
’	NULL
vo	NULL
99	NULL
990	NULL
f	NULL
4	NULL
,	NULL
7	NULL
n	NULL
%	NULL
%	NULL
&	NULL
%	NULL
*s	NULL
*y	NULL
.	NULL

&	NULL
4	NULL
)	NULL
.	NULL

7	NULL
7a	NULL
7	NULL
C.	NULL
Probe	NULL
~42/-76	NULL
C	NULL
's	NULL
Cell	NULL
Line	NULL
45	NULL
Jurkat	NULL
HeLa	NULL
Jurkat	NULL
HeLa	NULL
T	NULL
T	NULL
1	NULL
C	NULL
T	NULL
1	NULL
Competitor	NULL
|	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Role	NULL
of	NULL
Ets	NULL
sites	NULL
in	NULL
controlling	NULL
«	NULL
4	NULL
expression	NULL
.	NULL

A	NULL
,	NULL
the	NULL
Ets	NULL
sites	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
in	NULL
the	NULL
a4	NULL
gene	NULL
promoter	NULL
are	NULL
transcriptional	NULL
activators	NULL
.	NULL

The	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
in	NULL
pTACAT	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
SV40	NULL
early	NULL
gene	NULL
TATA	NULL
box	NULL
driving	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Weintraub	NULL
and	NULL
Dean	NULL
,	NULL
1992	NULL
)	NULL
to	NULL
create	NULL
pTA	NULL
(	NULL
-42/-76	NULL
)	NULL
CAT	NULL
.	NULL

Constructs	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

100	NULL
%	NULL
relative	NULL
activity	NULL
corresponds	NULL
to	NULL
49	NULL
%	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
to	NULL
acetylated	NULL
forms	NULL
.	NULL

B	NULL
,	NULL
gel	NULL
retardation	NULL
assay	NULL
showing	NULL
binding	NULL
of	NULL
Jurkat	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
position	NULL
-42	NULL
to	NULL
-76	NULL
bp	NULL
region	NULL
of	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
.	NULL

Specific	NULL
complexes	NULL
(	NULL
a	NULL
and	NULL
b	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

``	NULL
NS	NULL
``	NULL
denotes	NULL
a	NULL
nonspecific	NULL
complex	NULL
.	NULL

The	NULL
region	NULL
from	NULL
position	NULL
-42	NULL
to	NULL
-63	NULL
bp	NULL
only	NULL
contains	NULL
the	NULL
two	NULL
adjacent	NULL
downstream	NULL
Ets	NULL
sites	NULL
at	NULL
positions	NULL
-54	NULL
and	NULL
-50	NULL
bp	NULL
.	NULL

``	NULL
Moloney	NULL
``	NULL
and	NULL
``	NULL
SV40	NULL
``	NULL
are	NULL
Ets	NULL
sites	NULL
from	NULL
the	NULL
Moloney	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
and	NULL
the	NULL
SV40	NULL
enhancer	NULL
,	NULL
respectively	NULL
.	NULL

C	NULL
,	NULL
gel	NULL
retardation	NULL
assays	NULL
comparing	NULL
binding	NULL
of	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
position	NULL
-42	NULL
to	NULL
-76	NULL
bp	NULL
region	NULL
of	NULL
the	NULL
a4	NULL
gene	NULL
promoter	NULL
.	NULL

The	NULL
panel	NULL
on	NULL
the	NULL
right	NULL
is	NULL
a	NULL
shorter	NULL
exposure	NULL
of	NULL
the	NULL
panel	NULL
on	NULL
the	NULL
left	NULL
which	NULL
shows	NULL
the	NULL
separation	NULL
of	NULL
complex	NULL
a	NULL
and	NULL
b	NULL
with	NULL
the	NULL
Jurkat	NULL
extract	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
a	NULL
specific	NULL
complex	NULL
that	NULL
is	NULL
seen	NULL
with	NULL
the	NULL
HeLa	NULL
but	NULL
not	NULL
with	NULL
the	NULL
Jurkat	NULL
extract	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
was	NULL
included	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

dation	NULL
assays	NULL
that	NULL
were	NULL
specifically	NULL
competed	NULL
by	NULL
unlabeled	NULL
probes	NULL
.	NULL

However	NULL
,	NULL
these	NULL
bands	NULL
were	NULL
never	NULL
reproducible	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
represent	NULL
partial	NULL
degradation	NULL
products	NULL
.	NULL

Competition	NULL
with	NULL
an	NULL
Ets	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
Moloney	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
inhibited	NULL
formation	NULL
of	NULL
complex	NULL
b	NULL
,	NULL
but	NULL
not	NULL
complex	NULL
a	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
complex	NULL
b	NULL
contains	NULL
an	NULL
Ets	NULL
protein	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
competition	NULL
with	NULL
a	NULL
second	NULL
Ets	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
gene	NULL
promoter	NULL
,	NULL
which	NULL
binds	NULL
preferentially	NULL
to	NULL
the	NULL
B-cell-specific	NULL
Ets	NULL
protein	NULL
,	NULL
PU.1	NULL
(	NULL
Klemsz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
-42	NULL
to	NULL
-76	NULL
bp	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Neither	NULL
the	NULL
Moloney	NULL
virus	NULL
nor	NULL
the	NULL
«	NULL
4	NULL
Ets	NULL
sites	NULL
appeared	NULL
to	NULL
bind	NULL
to	NULL
PU.1	NULL
in	NULL
extracts	NULL
from	NULL
the	NULL
B-cell	NULL
line	NULL
Raji	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
emphasize	NULL
the	NULL
fact	NULL
that	NULL
sequences	NULL
flanking	NULL
the	NULL
Ets	NULL
core	NULL
consensus	NULL
allow	NULL
different	NULL
sites	NULL
to	NULL
discriminate	NULL
among	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
.	NULL

When	NULL
extract	NULL
from	NULL
HeLa	NULL
cells	NULL
was	NULL
used	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
complex	NULL
b	NULL
was	NULL
evident	NULL
but	NULL
no	NULL
complex	NULL
a	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
formation	NULL
of	NULL
complex	NULL
a	NULL
is	NULL
cell	NULL
type-specific	NULL
.	NULL

And	NULL
,	NULL
since	NULL
the	NULL
a4	NULL
gene	NULL
Ets	NULL
sites	NULL
show	NULL
little	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
formation	NULL
of	NULL
complex	NULL
a	NULL
could	NULL
be	NULL
linked	NULL
to	NULL
efficient	NULL
transcriptional	NULL
activation	NULL
.	NULL

Additionally	NULL
,	NULL
a	NULL
more	NULL
rapidly	NULL
migrating	NULL
complex	NULL
,	NULL
which	NULL
was	NULL
not	NULL
evident	NULL
with	NULL
the	NULL
Jurkat	NULL
extract	NULL
,	NULL
was	NULL
found	NULL
with	NULL
the	NULL
HeLa	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
unknown	NULL
;	NULL
however	NULL
,	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
contribute	NULL
to	NULL
transcriptional	NULL
activation	NULL
,	NULL
since	NULL
these	NULL
Ets	NULL
sites	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
active	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Complex	NULL
b	NULL
Is	NULL
GABPa	NULL
and	NULL
GABPB	NULL
,	NULL
Whereas	NULL
Complex	NULL
a	NULL
Contains	NULL
an	NULL
Unknown	NULL
Ets	NULL
Protein-To	NULL
determine	NULL
which	NULL
Ets	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
,	NULL
15656	NULL
antibodies	NULL
that	NULL
recognize	NULL
specific	NULL
Ets	NULL
members	NULL
were	NULL
used	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

A	NULL
pan	NULL
Ets	NULL
antibody	NULL
to	NULL
the	NULL
Ets	NULL
family	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
which	NULL
inhibits	NULL
binding	NULL
of	NULL
Ets	NULL
proteins	NULL
to	NULL
DNA	NULL
(	NULL
Bhat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
blocked	NULL
formation	NULL
of	NULL
complex	NULL
a	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
complex	NULL
b	NULL
,	NULL
suggesting	NULL
that	NULL
both	NULL
complexes	NULL
contain	NULL
Ets	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Neither	NULL
anti-Ets-1	NULL
nor	NULL
anti-Ets-2	NULL
Probe	NULL
-42/-76	NULL
Competitor/	NULL
I	NULL
x0	NULL
C	NULL
0x9	NULL
]	NULL
Antibody	NULL
__	NULL
¥	NULL
-	NULL
_	NULL
._	NULL
;	NULL
P	NULL
g	NULL
``	NULL
,	NULL
C	NULL
b*-	NULL
&	NULL
Co	NULL
e	NULL
c*	NULL
4	NULL
a=	NULL
b	NULL
-	NULL
a	NULL
.	NULL

“	NULL
m	NULL
hae	NULL
ves	NULL
--	NULL
t	NULL
bot	NULL
tam	NULL
pant	NULL
W	NULL
W	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

The	NULL
a4	NULL
gene	NULL
5'-flanking	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
binds	NULL
GABP	NULL
«	NULL
/GABPB	NULL
and	NULL
a	NULL
unique	NULL
Ets	NULL
complex	NULL
.	NULL

Antibodies	NULL
that	NULL
recognize	NULL
Ets-1	NULL
(	NULL
E44	NULL
)	NULL
,	NULL
GABPa	NULL
(	NULL
«	NULL
Ab	NULL
)	NULL
,	NULL
GABPB	NULL
(	NULL
BAb	NULL
)	NULL
,	NULL
Ets-2	NULL
(	NULL
U244	NULL
)	NULL
,	NULL
and	NULL
the	NULL
common	NULL
Ets	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
Pan	NULL
Ets	NULL
)	NULL
were	NULL
used	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
complex	NULL
that	NULL
is	NULL
observed	NULL
upon	NULL
addition	NULL
of	NULL
E44	NULL
is	NULL
designated	NULL
c*	NULL
.	NULL

In	NULL
the	NULL
first	NULL
lane	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
corresponding	NULL
to	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
was	NULL
included	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

Supershifted	NULL
complexes	NULL
are	NULL
denoted	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

A.	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
deleting	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
in	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
on	NULL
transcription	NULL
and	NULL
Ets	NULL
binding	NULL
.	NULL

A	NULL
,	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
alone	NULL
has	NULL
no	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
deletion	NULL
of	NULL
this	NULL
site	NULL
has	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
two	NULL
3'-most	NULL
Ets	NULL
sites	NULL
.	NULL

The	NULL
regions	NULL
between	NULL
positions	NULL
-42	NULL
and	NULL
-63	NULL
bp	NULL
(	NULL
contains	NULL
the	NULL
two	NULL
3'-most	NULL
Ets	NULL
sites	NULL
)	NULL
and	NULL
-62	NULL
and	NULL
-73	NULL
bp	NULL
(	NULL
contains	NULL
only	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
)	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
in	NULL
pTACAT	NULL
to	NULL
create	NULL
pTA	NULL
(	NULL
-42/	NULL
-63	NULL
)	NULL
CAT	NULL
and	NULL
pTA	NULL
(	NULL
-62/-73	NULL
)	NULL
CAT	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
pTA	NULL
(	NULL
-42/-76	NULL
)	NULL
CAT	NULL
,	NULL
which	NULL
contains	NULL
all	NULL
three	NULL
Ets	NULL
sites	NULL
,	NULL
in	NULL
transfection	NULL
assays	NULL
into	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

B	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
changes	NULL
the	NULL
pattern	NULL
of	NULL
Ets	NULL
binding	NULL
.	NULL

When	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-63	NULL
and	NULL
-42	NULL
bp	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-67	NULL
bp	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
with	NULL
Jurkat	NULL
nuclear	NULL
proteins	NULL
,	NULL
complex	NULL
a	NULL
did	NULL
not	NULL
form	NULL
.	NULL

A	NULL
band	NULL
that	NULL
comigrated	NULL
with	NULL
complex	NULL
b	NULL
was	NULL
present	NULL
100	NULL
75-	NULL
50	NULL
Relative	NULL
CAT	NULL
Activity	NULL
25	NULL
along	NULL
with	NULL
a	NULL
new	NULL
,	NULL
more	NULL
rapidly	NULL
migrating	NULL
,	NULL
be	NULL
?	NULL

A	NULL
)	NULL
;	NULL
4°	NULL
)	NULL
?	NULL

complex	NULL
c.	NULL
Where	NULL
indicated	NULL
,	NULL
a	NULL
20-fold	NULL
mo-	NULL
K	NULL
?	NULL

K7	NULL
ﬁe	NULL
lar	NULL
excess	NULL
of	NULL
competitor	NULL
was	NULL
included	NULL
in	NULL
é	NULL
)	NULL
ig	NULL
V2	NULL
)	NULL
the	NULL
assay	NULL
.	NULL

100	NULL
%	NULL
relative	NULL
activity	NULL
corre-	NULL
90	NULL
QC	NULL
.	NULL

go	NULL
sponds	NULL
to	NULL
49	NULL
%	NULL
conversion	NULL
of	NULL
chloram-	NULL
1	NULL
,	NULL
7	NULL
,	NULL
7	NULL
,	NULL
phenicol	NULL
to	NULL
acetylated	NULL
forms	NULL
.	NULL

Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
had	NULL
an	NULL
effect	NULL
on	NULL
complex	NULL
a	NULL
or	NULL
b	NULL
,	NULL
therefore	NULL
these	NULL
Ets	NULL
members	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
bind	NULL
the	NULL
a4	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Although	NULL
anti-Ets-1	NULL
failed	NULL
to	NULL
supershift	NULL
complex	NULL
a	NULL
or	NULL
b	NULL
,	NULL
a	NULL
new	NULL
,	NULL
more	NULL
slowly	NULL
migrating	NULL
,	NULL
complex	NULL
``	NULL
c*	NULL
``	NULL
was	NULL
evident	NULL
when	NULL
this	NULL
antibody	NULL
was	NULL
present	NULL
.	NULL

This	NULL
antibody	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
induce	NULL
formation	NULL
of	NULL
a	NULL
stable	NULL
Ets-1	NULL
complex	NULL
(	NULL
Seth	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
this	NULL
antibody	NULL
induces	NULL
the	NULL
binding	NULL
of	NULL
Ets-1	NULL
,	NULL
which	NULL
does	NULL
not	NULL
normally	NULL
bind	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
to	NULL
-76	NULL
bp	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Complex	NULL
b	NULL
was	NULL
completely	NULL
supershifted	NULL
into	NULL
the	NULL
well	NULL
by	NULL
antibodies	NULL
to	NULL
either	NULL
the	NULL
ubiquitous	NULL
Ets	NULL
protein	NULL
,	NULL
GABPa	NULL
,	NULL
or	NULL
its	NULL
binding	NULL
partner	NULL
the	NULL
Notch-like	NULL
protein	NULL
,	NULL
GABPB	NULL
(	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
complex	NULL
b	NULL
is	NULL
GABP	NULL
«	NULL
/GABP	NULL
$	NULL
B	NULL
.	NULL

Based	NULL
on	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
antibodies	NULL
to	NULL
different	NULL
Ets	NULL
members	NULL
and	NULL
competition	NULL
with	NULL
known	NULL
binding	NULL
sites	NULL
for	NULL
specific	NULL
Ets	NULL
proteins	NULL
,	NULL
the	NULL
Ets	NULL
protein	NULL
in	NULL
complex	NULL
a	NULL
is	NULL
not	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
PU.1	NULL
,	NULL
or	NULL
GABPa	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
5'-Most	NULL
Ets	NULL
Site	NULL
Changes	NULL
the	NULL
Pattern	NULL
of	NULL
Ets	NULL
Protein	NULL
Binding	NULL
but	NULL
Does	NULL
Not	NULL
Block	NULL
Transcriptional	NULL
Activity-The	NULL
region	NULL
between	NULL
position	NULL
-76	NULL
and	NULL
-42	NULL
bp	NULL
was	NULL
divided	NULL
into	NULL
two	NULL
parts	NULL
:	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
(	NULL
position	NULL
-62	NULL
to	NULL
-73	NULL
bp	NULL
)	NULL
and	NULL
the	NULL
two	NULL
adjacent	NULL
3'-most	NULL
Ets	NULL
sites	NULL
(	NULL
position	NULL
-42	NULL
to	NULL
-63	NULL
bp	NULL
)	NULL
.	NULL

The	NULL
region	NULL
between	NULL
position	NULL
-62	NULL
and	NULL
-73	NULL
bp	NULL
was	NULL
cloned	NULL
into	NULL
pTACAT	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

Neither	NULL
a	NULL
monomer	NULL
nor	NULL
a	NULL
dimer	NULL
of	NULL
the	NULL
sequence	NULL
containing	NULL
this	NULL
upstream	NULL
Ets	NULL
site	NULL
stimulated	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
lack	NULL
of	NULL
transcriptional	NULL
activity	NULL
,	NULL
this	NULL
site	NULL
did	NULL
not	NULL
bind	NULL
nuclear	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-63	NULL
bp	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
two	NULL
downstream	NULL
Ets	NULL
sites	NULL
,	NULL
was	NULL
sufficient	NULL
to	NULL
stimulate	NULL
expression	NULL
from	NULL
pTACAT	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
gel	NULL
retardation	NULL
assays	NULL
these	NULL
two	NULL
downstream	NULL
sites	NULL
at	NULL
positions	NULL
-54	NULL
and	NULL
-50	NULL
bp	NULL
formed	NULL
a	NULL
complex	NULL
that	NULL
comigrated	NULL
with	NULL
complex	NULL
b	NULL
;	NULL
however	NULL
,	NULL
no	NULL
complex	NULL
a	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
a	NULL
new	NULL
complex	NULL
that	NULL
migrated	NULL
more	NULL
rapidly	NULL
than	NULL
complex	NULL
b	NULL
(	NULL
complex	NULL
¢	NULL
)	NULL
was	NULL
formed	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
complexes	NULL
b	NULL
and	NULL
c	NULL
varied	NULL
somewhat	NULL
from	NULL
experiment	NULL
to	NULL
experiment	NULL
.	NULL

Both	NULL
complex	NULL
b	NULL
and	NULL
complex	NULL
c	NULL
were	NULL
competed	NULL
by	NULL
the	NULL
Ets	NULL
site	NULL
from	NULL
Moloney	NULL
virus	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
Ets	NULL
site	NULL
from	NULL
SV40	NULL
which	NULL
binds	NULL
preferentially	NULL
to	NULL
B	NULL
.	NULL

Probe	NULL
~42/-63	NULL
B	NULL
ﬁn	NULL
)	NULL
«	NULL
b	NULL
000	NULL
(	NULL
x	NULL
]	NULL
.	NULL

®	NULL
S	NULL
Competitor	NULL
~	NULL
59	NULL
>	NULL
$	NULL
1	NULL
}	NULL
S	NULL
}	NULL
o	NULL
>	NULL
_o	NULL
+	NULL
b-	NULL
-	NULL
bas	NULL
H	NULL
Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
Probe	NULL
~42/-63	NULL
I	NULL
1	NULL
Competitor/	NULL
&	NULL
I	NULL
Antibody	NULL
$	NULL
1	NULL
}	NULL
q	NULL
}	NULL
?	NULL

$	NULL
1	NULL
?	NULL

JP	NULL
Q	NULL
?	NULL

b*	NULL
ama	NULL
os	NULL
g	NULL
#	NULL
c+	NULL
b-4	NULL
15657	NULL
Probe	NULL
~42/-63	NULL
[	NULL
1	NULL
y	NULL
0	NULL
?	NULL

®	NULL
Competitor/	NULL
“	NULL
b	NULL
J	NULL
o	NULL
``	NULL
]	NULL
&	NULL
88	NULL
``	NULL
66	NULL
``	NULL
of	NULL
od	NULL
Antibody/	NULL
a	NULL
``	NULL
2°	NULL
&	NULL
&	NULL
J	NULL
Protein	NULL
0°	NULL
q	NULL
)	NULL
”	NULL
oC	NULL
co	NULL
oC	NULL
cC	NULL
07	NULL
b*	NULL
-g	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

The	NULL
two	NULL
adjacent	NULL
3'-most	NULL
Ets	NULL
sites	NULL
bind	NULL
GABP	NULL
«	NULL
/GABP	NULL
$	NULL
and	NULL
an	NULL
Ets-1	NULL
complex	NULL
.	NULL

A	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
anti-Ets	NULL
antibodies	NULL
on	NULL
complexes	NULL
formed	NULL
between	NULL
Jurkat	NULL
nuclear	NULL
proteins	NULL
and	NULL
the	NULL
two	NULL
3'-most	NULL
Ets	NULL
sites	NULL
.	NULL

Antibodies	NULL
to	NULL
Ets-1	NULL
(	NULL
E44	NULL
)	NULL
,	NULL
Ets-2	NULL
(	NULL
U244	NULL
)	NULL
,	NULL
GABPa	NULL
(	NULL
«	NULL
Ab	NULL
)	NULL
or	NULL
GABPB	NULL
(	NULL
BAb	NULL
)	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
to	NULL
gel	NULL
retardation	NULL
assays	NULL
containing	NULL
Jurkat	NULL
nuclear	NULL
proteins	NULL
,	NULL
and	NULL
the	NULL
region	NULL
from	NULL
position	NULL
-42	NULL
to	NULL
-63	NULL
bp	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

In	NULL
the	NULL
second	NULL
lane	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
containing	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-63	NULL
bp	NULL
was	NULL
included	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

B	NULL
,	NULL
the	NULL
two	NULL
3'-most	NULL
Ets	NULL
sites	NULL
bind	NULL
purified	NULL
GABPa	NULL
and	NULL
GABP	NULL
«	NULL
/GABP	NULL
$	NULL
,	NULL
but	NULL
not	NULL
purified	NULL
Ets-1	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
purified	NULL
Ets	NULL
proteins	NULL
,	NULL
or	NULL
anti-Ets	NULL
antibodies	NULL
,	NULL
were	NULL
present	NULL
in	NULL
the	NULL
assays	NULL
.	NULL

The	NULL
supershifted	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
a	NULL
complex	NULL
with	NULL
GABPa	NULL
alone	NULL
.	NULL

PU.1	NULL
.	NULL

Consistent	NULL
with	NULL
their	NULL
inability	NULL
to	NULL
form	NULL
complex	NULL
a	NULL
,	NULL
the	NULL
two	NULL
Ets	NULL
sites	NULL
at	NULL
position	NULL
-50	NULL
and	NULL
-54	NULL
bp	NULL
alone	NULL
were	NULL
unable	NULL
to	NULL
block	NULL
formation	NULL
of	NULL
complex	NULL
a	NULL
when	NULL
they	NULL
were	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
even	NULL
though	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
alone	NULL
does	NULL
not	NULL
bind	NULL
Ets	NULL
proteins	NULL
,	NULL
it	NULL
must	NULL
collaborate	NULL
with	NULL
the	NULL
other	NULL
sites	NULL
to	NULL
form	NULL
complex	NULL
a	NULL
.	NULL

The	NULL
Two	NULL
3'-Most	NULL
Ets	NULL
Sites	NULL
at	NULL
Positions	NULL
-54	NULL
and	NULL
-50	NULL
bp	NULL
Bind	NULL
GABPa	NULL
«	NULL
/GABPB-Antibodies	NULL
that	NULL
recognize	NULL
different	NULL
Ets	NULL
members	NULL
were	NULL
used	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
with	NULL
the	NULL
two	NULL
downstream	NULL
Ets	NULL
sites	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Either	NULL
anti-GABPa	NULL
or	NULL
anti-GABPSG	NULL
completely	NULL
supershifted	NULL
complex	NULL
b	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
complex	NULL
consists	NULL
of	NULL
GABP	NULL
«	NULL
@	NULL
/GABPB	NULL
,	NULL
and	NULL
thus	NULL
indicating	NULL
that	NULL
these	NULL
two	NULL
downstream	NULL
sites	NULL
alone	NULL
are	NULL
sufficient	NULL
for	NULL
binding	NULL
GABP	NULL
«	NULL
/GABP	NULL
$	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
complex	NULL
b	NULL
is	NULL
composed	NULL
of	NULL
GABP	NULL
«	NULL
@	NULL
/GABPB	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
two	NULL
downstream	NULL
Ets	NULL
sites	NULL
to	NULL
bind	NULL
purified	NULL
GABPa	NULL
and	NULL
GABP	NULL
$	NULL
.	NULL

Addition	NULL
of	NULL
purified	NULL
GABPa	NULL
alone	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
complex	NULL
that	NULL
migrated	NULL
more	NULL
rapidly	NULL
than	NULL
complex	NULL
b	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

GABPa	NULL
alone	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
weakly	NULL
(	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
complex	NULL
is	NULL
GABPa	NULL
.	NULL

Purified	NULL
did	NULL
not	NULL
bind	NULL
alone	NULL
,	NULL
but	NULL
when	NULL
mixed	NULL
with	NULL
GABPa	NULL
,	NULL
a	NULL
complex	NULL
appeared	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
complex	NULL
b.	NULL
Anti-GABPa	NULL
or	NULL
anti-GABPRB	NULL
supershifted	NULL
this	NULL
complex	NULL
,	NULL
indicating	NULL
that	NULL
complex	NULL
b	NULL
is	NULL
indeed	NULL
Deletion	NULL
of	NULL
the	NULL
5'-Most	NULL
Ets	NULL
Site	NULL
Not	NULL
Only	NULL
Blocks	NULL
Formation	NULL
of	NULL
Complex	NULL
a	NULL
,	NULL
It	NULL
Results	NULL
in	NULL
the	NULL
Binding	NULL
of	NULL
a	NULL
New	NULL
Heterotypic	NULL
Ets-1-containing	NULL
Complex	NULL
to	NULL
the	NULL
Two	NULL
Downstream	NULL
Ets	NULL
Sites-As	NULL
described	NULL
above	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
not	NULL
only	NULL
blocked	NULL
formation	NULL
of	NULL
complex	NULL
a	NULL
,	NULL
it	NULL
resulted	NULL
in	NULL
formation	NULL
of	NULL
a	NULL
new	NULL
complex	NULL
c	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Anti-Ets-1	NULL
supershifted	NULL
complex	NULL
c	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
contains	NULL
Ets-1	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
removal	NULL
of	NULL
the	NULL
5'-most	NULL
Ets	NULL
site	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
formation	NULL
of	NULL
complex	NULL
a	NULL
,	NULL
permits	NULL
the	NULL
two	NULL
downstream	NULL
sites	NULL
to	NULL
bind	NULL
Ets-1	NULL
.	NULL

Interestingly	NULL
,	NULL
purified	NULL
Ets-1	NULL
did	NULL
not	NULL
bind	NULL
these	NULL
two	NULL
downstream	NULL
Ets	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
although	NULL
it	NULL
did	NULL
bind	NULL
efficiently	NULL
to	NULL
the	NULL
Ets	NULL
site	NULL
from	NULL
Moloney	NULL
virus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
bind	NULL
Ets-1	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Ets-1	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
bind	NULL
the	NULL
two	NULL
downstream	NULL
Ets	NULL
sites	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
must	NULL
interact	NULL
with	NULL
another	NULL
protein	NULL
to	NULL
form	NULL
complex	NULL
c.	NULL
The	NULL
3'-Most	NULL
Ets	NULL
Site	NULL
at	NULL
Position	NULL
-50	NULL
bp	NULL
Binds	NULL
GABP	NULL
«	NULL
/	NULL
GABPB	NULL
and	NULL
Can	NULL
Activate	NULL
Transcription	NULL
to	NULL
a	NULL
Limited	NULL
Degree-Mutations	NULL
in	NULL
the	NULL
Ets	NULL
sites	NULL
at	NULL
positions	NULL
-50	NULL
and	NULL
-54	NULL
bp	NULL
were	NULL
created	NULL
to	NULL
determine	NULL
whether	NULL
both	NULL
of	NULL
these	NULL
adjacent	NULL
sites	NULL
were	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mutations	NULL
in	NULL
both	NULL
sites	NULL
(	NULL
M	NULL
I	NULL
)	NULL
eliminated	NULL
transcriptional	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
lack	NULL
of	NULL
transcriptional	NULL
activity	NULL
,	NULL
this	NULL
mutant	NULL
did	NULL
not	NULL
bind	NULL
nuclear	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
single	NULL
base	NULL
mutation	NULL
was	NULL
then	NULL
made	NULL
in	NULL
the	NULL
3'-most	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
(	NULL
M	NULL
II	NULL
)	NULL
.	NULL

This	NULL
mutant	NULL
also	NULL
failed	NULL
to	NULL
activate	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
3'-most	NULL
Ets	NULL
site	NULL
is	NULL
essential	NULL
for	NULL
transcriptional	NULL
activity	NULL
.	NULL

And	NULL
like	NULL
M	NULL
I	NULL
,	NULL
M	NULL
II	NULL
failed	NULL
to	NULL
bind	NULL
nuclear	NULL
protein	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-54	NULL
bp	NULL
site	NULL
was	NULL
then	NULL
mutated	NULL
(	NULL
M	NULL
III-V	NULL
;	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Although	NULL
M	NULL
III	NULL
was	NULL
significantly	NULL
less	NULL
active	NULL
than	NULL
the	NULL
wild	NULL
type	NULL
sequence	NULL
,	NULL
it	NULL
did	NULL
activate	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
seen	NULL
with	NULL
M	NULL
IV	NULL
and	NULL
M	NULL
V	NULL
,	NULL
which	NULL
also	NULL
mutate	NULL
the	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-54	NULL
bp	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
alone	NULL
is	NULL
transcriptionally	NULL
active	NULL
.	NULL

M	NULL
III-V	NULL
all	NULL
gave	NULL
the	NULL
same	NULL
pattern	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
:	NULL
they	NULL
only	NULL
formed	NULL
a	NULL
complex	NULL
that	NULL
comigrated	NULL
with	NULL
b	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
and	NULL
results	NULL
Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
100	NULL
.	NULL

Probe	NULL
-	NULL
-42/-63	NULL
M	NULL
Ill	NULL
FAL	NULL
--	NULL
-I	NULL
-54	NULL
-	NULL
-50	NULL
R	NULL
$	NULL
6	NULL
,	NULL
th	NULL
G	NULL
@	NULL
GaAGGAAGGAAGT	NULL
-WT	NULL
Competitor	NULL
-	NULL
-	NULL
®	NULL
»	NULL
``	NULL
»	NULL
Di	NULL
Al	NULL
A	NULL
-M	NULL
I	NULL
e	NULL
75-	NULL
e	NULL
3	NULL
ii	NULL
A	NULL
-M	NULL
I1	NULL
_	NULL
>	NULL
G	NULL
-M	NULL
III	NULL
%	NULL
b-	NULL
trg	NULL
)	NULL
t-	NULL
«	NULL
+	NULL
<	NULL
4	NULL
--	NULL
-M	NULL
V	NULL
4	NULL
so	NULL
d	NULL
NS	NULL
-	NULL
H	NULL
|	NULL
>	NULL
ts	NULL
N§_	NULL
‘	NULL
4	NULL
§	NULL
=-	NULL
t	NULL
4	NULL
@	NULL
C	NULL
&	NULL
25	NULL
-	NULL
NS	NULL
-	NULL
.	NULL

h	NULL
}	NULL
‘	NULL
0	NULL
O	NULL
,	NULL
0	NULL
,	NULL
0	NULL
&	NULL
,	NULL
O	NULL
,	NULL
4	NULL
``	NULL
X	NULL
a	NULL
a	NULL
a	NULL
+	NULL
C	NULL
,	NULL
``	NULL
z	NULL
,	NULL
``	NULL
z	NULL
,	NULL
``	NULL
v	NULL
,	NULL
``	NULL
y	NULL
,	NULL
``	NULL
v	NULL
T	NULL
»	NULL
Rau	NULL
Co	NULL
Cau	NULL
Cu	NULL
,	NULL
*	NULL
``	NULL
s	NULL
,	NULL
%	NULL
,	NULL
%	NULL
,	NULL
%	NULL
,	NULL
%	NULL
J	NULL
A	NULL
J	NULL
#	NULL
J	NULL
a	NULL
,	NULL
70	NULL
,	NULL
1	NULL
,	NULL
41	NULL
,	NULL
A	NULL
h/S	NULL
4	NULL
)	NULL
.	NULL

‘	NULL
9	NULL
‘	NULL
4	NULL
‘	NULL
4	NULL
)	NULL
*	NULL
,	NULL
40	NULL
,	NULL
$	NULL
1	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

The	NULL
3'-most	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
is	NULL
critical	NULL
for	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
it	NULL
forms	NULL
a	NULL
complex	NULL
that	NULL
comigrates	NULL
with	NULL
complex	NULL
b	NULL
.	NULL

A	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
two	NULL
3'-most	NULL
Ets	NULL
sites	NULL
on	NULL
transcriptional	NULL
activity	NULL
.	NULL

Mutations	NULL
M	NULL
I-V	NULL
are	NULL
shown	NULL
along	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
WT	NULL
)	NULL
sequence	NULL
.	NULL

M	NULL
I	NULL
mutates	NULL
both	NULL
the	NULL
site	NULL
at	NULL
position	NULL
-54	NULL
bp	NULL
and	NULL
the	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
,	NULL
whereas	NULL
M	NULL
II	NULL
only	NULL
mutates	NULL
the	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
,	NULL
and	NULL
M	NULL
III-V	NULL
only	NULL
mutates	NULL
the	NULL
site	NULL
at	NULL
position	NULL
-54	NULL
bp	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
these	NULL
mutants	NULL
was	NULL
compared	NULL
in	NULL
transfection	NULL
assays	NULL
into	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

M	NULL
IV	NULL
and	NULL
M	NULL
V	NULL
showed	NULL
the	NULL
same	NULL
activity	NULL
as	NULL
M	NULL
III	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

100	NULL
%	NULL
relative	NULL
activity	NULL
corresponds	NULL
to	NULL
49	NULL
%	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
to	NULL
acetylated	NULL
forms	NULL
.	NULL

B	NULL
,	NULL
the	NULL
3'-most	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
is	NULL
sufficient	NULL
for	NULL
binding	NULL
a	NULL
complex	NULL
that	NULL
comigrates	NULL
with	NULL
complex	NULL
b	NULL
;	NULL
however	NULL
,	NULL
this	NULL
site	NULL
alone	NULL
does	NULL
not	NULL
form	NULL
the	NULL
Ets-1-containing	NULL
complex	NULL
c.	NULL
Assays	NULL
contain	NULL
Jurkat	NULL
nuclear	NULL
proteins	NULL
and	NULL
M	NULL
III	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
M	NULL
III	NULL
competitor	NULL
was	NULL
included	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

M	NULL
IV	NULL
and	NULL
M	NULL
V	NULL
showed	NULL
the	NULL
same	NULL
pattern	NULL
as	NULL
M	NULL
III	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

not	NULL
shown	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
GABPa	NULL
or	NULL
GABPB	NULL
supershifted	NULL
this	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
M	NULL
III	NULL
bound	NULL
purified	NULL
GABP	NULL
«	NULL
/	NULL
GABP	NULL
,	NULL
and	NULL
this	NULL
complex	NULL
was	NULL
also	NULL
supershifted	NULL
by	NULL
anti-GABPa	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
single	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
is	NULL
sufficient	NULL
for	NULL
binding	NULL
GABP	NULL
«	NULL
@	NULL
/GABPB	NULL
.	NULL

Anti-Ets-1	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
binding	NULL
to	NULL
M	NULL
III	NULL
,	NULL
indicating	NULL
that	NULL
M	NULL
III	NULL
does	NULL
not	NULL
bind	NULL
Ets-1	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Both	NULL
adjacent	NULL
Ets	NULL
sites	NULL
at	NULL
positions	NULL
-50	NULL
and	NULL
-54	NULL
bp	NULL
are	NULL
then	NULL
required	NULL
for	NULL
binding	NULL
Ets-1	NULL
,	NULL
but	NULL
not	NULL
GABP	NULL
«	NULL
/	NULL
GABPB	NULL
.	NULL

These	NULL
results	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
transfection	NULL
data	NULL
,	NULL
indicate	NULL
that	NULL
the	NULL
GABP	NULL
&	NULL
@	NULL
/GABPB	NULL
complex	NULL
is	NULL
sufficient	NULL
for	NULL
at	NULL
least	NULL
some	NULL
level	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
most	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
Ets	NULL
sites	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
an	NULL
unidentified	NULL
complex	NULL
of	NULL
Ets	NULL
proteins	NULL
that	NULL
results	NULL
from	NULL
a	NULL
synergistic	NULL
interaction	NULL
between	NULL
the	NULL
three	NULL
different	NULL
Ets	NULL
sites	NULL
.	NULL

In	NULL
situations	NULL
where	NULL
complex	NULL
a	NULL
does	NULL
not	NULL
form	NULL
,	NULL
a	NULL
heterotypic	NULL
Ets-1	NULL
complex	NULL
can	NULL
replace	NULL
complex	NULL
a	NULL
and	NULL
efficiently	NULL
stimulate	NULL
promoter	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
although	NULL
M	NULL
IV	NULL
disrupts	NULL
the	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-54	NULL
bp	NULL
,	NULL
switching	NULL
the	NULL
G	NULL
nucleotide	NULL
to	NULL
an	NULL
A	NULL
nucleotide	NULL
in	NULL
this	NULL
mutant	NULL
results	NULL
in	NULL
formation	NULL
of	NULL
a	NULL
new	NULL
Ets	NULL
core	NULL
GGAA	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
original	NULL
site	NULL
at	NULL
position	NULL
-54	NULL
bp	NULL
,	NULL
this	NULL
new	NULL
GGAA	NULL
core	NULL
seems	NULL
to	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
transcriptional	NULL
activity	NULL
or	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
core	NULL
alone	NULL
is	NULL
not	NULL
functional	NULL
or	NULL
that	NULL
it	NULL
can	NULL
not	NULL
synergize	NULL
with	NULL
the	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
to	NULL
form	NULL
the	NULL
Ets-1-containing	NULL
complex	NULL
c.	NULL
DISCUSSION	NULL
We	NULL
present	NULL
evidence	NULL
here	NULL
that	NULL
transcription	NULL
of	NULL
the	NULL
a4	NULL
integrin	NULL
gene	NULL
is	NULL
dependent	NULL
upon	NULL
three	NULL
Ets	NULL
sites	NULL
located	NULL
between	NULL
position	NULL
-42	NULL
and	NULL
-76	NULL
bp	NULL
of	NULL
the	NULL
human	NULL
a4	NULL
gene	NULL
,	NULL
which	NULL
all	NULL
share	NULL
the	NULL
same	NULL
GGAA	NULL
core	NULL
sequence	NULL
.	NULL

The	NULL
3'-most	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
is	NULL
sufficient	NULL
for	NULL
binding	NULL
GABP	NULL
«	NULL
@	NULL
/GABP	NULL
$	NULL
B	NULL
,	NULL
and	NULL
this	NULL
site	NULL
can	NULL
activate	NULL
transcription	NULL
to	NULL
a	NULL
limited	NULL
degree	NULL
,	NULL
indicating	NULL
that	NULL
GABP	NULL
«	NULL
@	NULL
/GABPB	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Neither	NULL
of	NULL
the	NULL
other	NULL
two	NULL
sites	NULL
alone	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
nuclear	NULL
protein	NULL
or	NULL
activating	NULL
transcription	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
region	NULL
flanking	NULL
the	NULL
GGAA	NULL
core	NULL
is	NULL
important	NULL
in	NULL
conferring	NULL
binding	NULL
specificity	NULL
for	NULL
different	NULL
Ets	NULL
family	NULL
members	NULL
.	NULL

Others	NULL
have	NULL
suggested	NULL
that	NULL
two	NULL
GGAA	NULL
repeats	NULL
are	NULL
required	NULL
for	NULL
efficient	NULL
binding	NULL
of	NULL
GABPa	NULL
and	NULL
GABPB	NULL
(	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Carter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
,	NULL
a	NULL
single	NULL
Ets	NULL
site	NULL
is	NULL
sufficient	NULL
for	NULL
binding	NULL
to	NULL
GABP	NULL
«	NULL
/GABP	NULL
$	NULL
(	NULL
the	NULL
three	NULL
Ets	NULL
sites	NULL
together	NULL
bind	NULL
no	NULL
better	NULL
to	NULL
GABP	NULL
«	NULL
@	NULL
/GABP	NULL
$	NULL
than	NULL
the	NULL
single	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
GABPa	NULL
and	NULL
GABPB	NULL
had	NULL
been	NULL
in	NULL
question	NULL
;	NULL
however	NULL
,	NULL
recent	NULL
studies	NULL
of	NULL
the	NULL
cytochrome	NULL
oxidase	NULL
IV	NULL
gene	NULL
have	NULL
shown	NULL
that	NULL
these	NULL
Ets	NULL
members	NULL
are	NULL
transcriptional	NULL
activators	NULL
(	NULL
Carter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Virvasius	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
support	NULL
this	NULL
conclusion	NULL
.	NULL

Although	NULL
GABPa	NULL
and	NULL
GABP	NULL
$	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
some	NULL
role	NULL
in	NULL
controlling	NULL
«	NULL
4	NULL
gene	NULL
expression	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
they	NULL
could	NULL
be	NULL
solely	NULL
responsible	NULL
for	NULL
directing	NULL
the	NULL
pattern	NULL
of	NULL
«	NULL
4	NULL
tissue	NULL
expression	NULL
,	NULL
because	NULL
they	NULL
appear	NULL
to	NULL
be	NULL
ubiquitous	NULL
and	NULL
their	NULL
transcriptional	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
is	NULL
modest	NULL
.	NULL

Although	NULL
only	NULL
the	NULL
3'-most	NULL
Ets	NULL
site	NULL
in	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
is	NULL
capable	NULL
alone	NULL
of	NULL
binding	NULL
nuclear	NULL
protein	NULL
,	NULL
when	NULL
combined	NULL
,	NULL
the	NULL
three	NULL
Ets	NULL
sites	NULL
work	NULL
in	NULL
synergy	NULL
to	NULL
bind	NULL
another	NULL
complex	NULL
a	NULL
.	NULL

Formation	NULL
of	NULL
complex	NULL
a	NULL
is	NULL
cell	NULL
type-specific	NULL
correlates	NULL
with	NULL
increased	NULL
transcription	NULL
,	NULL
indicating	NULL
its	NULL
importance	NULL
for	NULL
promoter	NULL
Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
Probe	NULL
Antibody/	NULL
w	NULL
Competitor	NULL
_	NULL
¢	NULL
y	NULL
®	NULL
»	NULL
o	NULL
0	NULL
”	NULL
GVQY®\_	NULL
15659	NULL
Probe	NULL
M	NULL
III	NULL
I	NULL
8	NULL
¢®	NULL
079	NULL
]	NULL
Competitor/	NULL
x	NULL
$	NULL
&	NULL
a	NULL
``	NULL
Protein/	NULL
&	NULL
5°	NULL
6°	NULL
Q3	NULL
``	NULL
\	NULL
69	NULL
Q3	NULL
&	NULL
Antibody	NULL
_-	NULL
3	NULL
``	NULL
(	NULL
``	NULL
¢	NULL
oY	NULL
¢	NULL
L	NULL
b*-	NULL
Gime	NULL
bo	NULL
Gi	NULL
I	NULL
&	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

The	NULL
3'-most	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
is	NULL
sufficient	NULL
for	NULL
binding	NULL
to	NULL
GABP	NULL
«	NULL
@	NULL
GABPR	NULL
but	NULL
not	NULL
Ets-1	NULL
.	NULL

A	NULL
,	NULL
anti-GABPa	NULL
(	NULL
«	NULL
Ad	NULL
)	NULL
or	NULL
anti-GABPB	NULL
(	NULL
BAb	NULL
)	NULL
supershifts	NULL
complex	NULL
b	NULL
that	NULL
forms	NULL
with	NULL
the	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
were	NULL
done	NULL
with	NULL
Jurkat	NULL
nuclear	NULL
proteins	NULL
and	NULL
M	NULL
III	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Anti-Ets	NULL
antibodies	NULL
or	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
M	NULL
III	NULL
were	NULL
included	NULL
in	NULL
the	NULL
assays	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
supershifted	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

B	NULL
,	NULL
the	NULL
Ets	NULL
site	NULL
at	NULL
position	NULL
-50	NULL
bp	NULL
binds	NULL
purified	NULL
GABPa	NULL
(	NULL
arrow	NULL
)	NULL
and	NULL
GABP	NULL
&	NULL
@	NULL
/GABPB	NULL
.	NULL

Purified	NULL
proteins	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
,	NULL
anti-Ets	NULL
antibodies	NULL
,	NULL
and	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
competitors	NULL
were	NULL
included	NULL
in	NULL
the	NULL
assays	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
supershifted	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
a	NULL
complex	NULL
with	NULL
GABPa	NULL
alone	NULL
.	NULL

activity	NULL
.	NULL

Complex	NULL
a	NULL
is	NULL
blocked	NULL
by	NULL
an	NULL
antibody	NULL
to	NULL
the	NULL
conserved	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
contains	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
.	NULL

This	NULL
Ets	NULL
complex	NULL
appears	NULL
to	NULL
be	NULL
unique	NULL
,	NULL
because	NULL
it	NULL
is	NULL
not	NULL
competed	NULL
by	NULL
known	NULL
Ets	NULL
sites	NULL
from	NULL
Moloney	NULL
virus	NULL
or	NULL
from	NULL
the	NULL
SV40	NULL
enhancer	NULL
,	NULL
and	NULL
antibodies	NULL
to	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
GABPa	NULL
,	NULL
or	NULL
GABP	NULL
do	NULL
not	NULL
affect	NULL
it	NULL
.	NULL

The	NULL
complex	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
T-cells	NULL
;	NULL
it	NULL
is	NULL
also	NULL
found	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
where	NULL
the	NULL
a4	NULL
gene	NULL
promoter	NULL
is	NULL
active	NULL
.	NULL
``	NULL

Complex	NULL
a	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
HeLa	NULL
cells	NULL
where	NULL
the	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
«	NULL
4	NULL
promoter	NULL
showed	NULL
no	NULL
activity	NULL
.	NULL

Since	NULL
HeLa	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
«	NULL
4	NULL
,	NULL
there	NULL
is	NULL
then	NULL
a	NULL
correlation	NULL
between	NULL
expression	NULL
of	NULL
«	NULL
4	NULL
and	NULL
formation	NULL
of	NULL
complex	NULL
a	NULL
,	NULL
suggesting	NULL
an	NULL
important	NULL
role	NULL
for	NULL
complex	NULL
a	NULL
in	NULL
controlling	NULL
expression	NULL
of	NULL
«	NULL
4	NULL
in	NULL
vivo	NULL
.	NULL

Although	NULL
complex	NULL
a	NULL
does	NULL
not	NULL
form	NULL
in	NULL
HeLa	NULL
cells	NULL
the	NULL
GABPa	NULL
«	NULL
/GABPB	NULL
does	NULL
appear	NULL
to	NULL
form	NULL
,	NULL
yet	NULL
the	NULL
sites	NULL
are	NULL
not	NULL
active	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
GABPa	NULL
)	NULL
GABPGB	NULL
may	NULL
not	NULL
be	NULL
important	NULL
for	NULL
regulation	NULL
of	NULL
a4	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
GABP	NULL
@	NULL
/GABP	NULL
$	NULL
B	NULL
,	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
complex	NULL
forms	NULL
with	NULL
the	NULL
HeLa	NULL
cell	NULL
extract	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
this	NULL
complex	NULL
is	NULL
inhibitory	NULL
and	NULL
blocks	NULL
the	NULL
activity	NULL
of	NULL
GABPa	NULL
GABP	NULL
.	NULL

Neither	NULL
of	NULL
the	NULL
two	NULL
5'-most	NULL
Ets	NULL
sites	NULL
alone	NULL
can	NULL
bind	NULL
nuclear	NULL
protein	NULL
,	NULL
yet	NULL
they	NULL
appear	NULL
to	NULL
be	NULL
modulators	NULL
,	NULL
determining	NULL
the	NULL
nature	NULL
of	NULL
Ets	NULL
members	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
these	NULL
two	NULL
sites	NULL
,	NULL
only	NULL
GABP	NULL
«	NULL
/GABPB	NULL
binds	NULL
.	NULL

When	NULL
both	NULL
sites	NULL
are	NULL
present	NULL
,	NULL
the	NULL
unique	NULL
Ets	NULL
complex	NULL
described	NULL
above	NULL
also	NULL
forms	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
upstream	NULL
site	NULL
results	NULL
in	NULL
a	NULL
new	NULL
binding	NULL
pattern	NULL
:	NULL
GABP	NULL
«	NULL
/GABPB	NULL
still	NULL
binds	NULL
;	NULL
however	NULL
,	NULL
the	NULL
unique	NULL
complex	NULL
no	NULL
longer	NULL
forms	NULL
.	NULL

Instead	NULL
,	NULL
a	NULL
new	NULL
,	NULL
Ets-1	NULL
containing	NULL
complex	NULL
c	NULL
forms	NULL
.	NULL

Formation	NULL
of	NULL
complex	NULL
c	NULL
correlates	NULL
with	NULL
efficient	NULL
transcription	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
can	NULL
substitute	NULL
effi-	NULL
*	NULL
G.	NULL
D.	NULL
Rosen	NULL
and	NULL
D.	NULL
C.	NULL
Dean	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

ciently	NULL
for	NULL
complex	NULL
a	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

Ets-1	NULL
alone	NULL
does	NULL
not	NULL
bind	NULL
the	NULL
two	NULL
3'-most	NULL
sites	NULL
,	NULL
thus	NULL
complex	NULL
c	NULL
must	NULL
be	NULL
a	NULL
heterotypic	NULL
complex	NULL
composed	NULL
of	NULL
Ets-1	NULL
and	NULL
another	NULL
protein	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
Ets-1-containing	NULL
complex	NULL
becomes	NULL
important	NULL
for	NULL
«	NULL
4	NULL
gene	NULL
expression	NULL
in	NULL
vivo	NULL
in	NULL
situations	NULL
where	NULL
complex	NULL
a	NULL
does	NULL
not	NULL
form	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
pattern	NULL
of	NULL
Ets	NULL
members	NULL
,	NULL
which	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
a4	NULL
gene	NULL
promoter	NULL
,	NULL
is	NULL
cell-specific	NULL
and	NULL
developmentally	NULL
regulated	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
possibility	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
recently	NULL
that	NULL
Ets-1	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
differentiating	NULL
somite	NULL
,	NULL
on	NULL
neural	NULL
crest	NULL
cells	NULL
,	NULL
on	NULL
newly	NULL
forming	NULL
blood	NULL
vessels	NULL
,	NULL
and	NULL
at	NULL
sites	NULL
of	NULL
embryonic	NULL
hematopoiesis	NULL
in	NULL
blood	NULL
islands	NULL
of	NULL
the	NULL
yolk	NULL
sac	NULL
(	NULL
Pardanaud	NULL
and	NULL
Dieterlen-Lievre	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
these	NULL
are	NULL
all	NULL
sites	NULL
of	NULL
«	NULL
4	NULL
expression	NULL
during	NULL
embryogenesis	NULL
.	NULL
``	NULL

In	NULL
the	NULL
adult	NULL
,	NULL
Ets-1	NULL
is	NULL
present	NULL
in	NULL
lymphocytes	NULL
(	NULL
Chen	NULL
,	NULL
1985	NULL
)	NULL
,	NULL
a	NULL
principal	NULL
site	NULL
of	NULL
«	NULL
4	NULL
expression	NULL
in	NULL
normal	NULL
adults	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
Ets-1	NULL
could	NULL
then	NULL
be	NULL
important	NULL
for	NULL
defining	NULL
the	NULL
pattern	NULL
of	NULL
«	NULL
4	NULL
during	NULL
development	NULL
and	NULL
in	NULL
the	NULL
adult	NULL
.	NULL

Potentially	NULL
,	NULL
each	NULL
of	NULL
the	NULL
Ets	NULL
complexes	NULL
that	NULL
we	NULL
have	NULL
described	NULL
might	NULL
have	NULL
a	NULL
role	NULL
in	NULL
controlling	NULL
4	NULL
expression	NULL
.	NULL

Recent	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
lymphoid-specific	NULL
IgH	NULL
gene	NULL
expression	NULL
depends	NULL
upon	NULL
DNA	NULL
binding	NULL
by	NULL
two	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
,	NULL
PU.1	NULL
and	NULL
Ets-1	NULL
(	NULL
Nelsen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
requirement	NULL
for	NULL
two	NULL
different	NULL
Ets-domain	NULL
proteins	NULL
with	NULL
overlapping	NULL
expression	NULL
patterns	NULL
(	NULL
i.e	NULL
.	NULL

GABPa	NULL
and	NULL
either	NULL
Ets-1	NULL
or	NULL
the	NULL
unidentified	NULL
Ets	NULL
protein	NULL
)	NULL
could	NULL
confer	NULL
an	NULL
additional	NULL
degree	NULL
of	NULL
regulatory	NULL
specificity	NULL
on	NULL
the	NULL
«	NULL
4	NULL
gene	NULL
promoter	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
C.	NULL
Thompson	NULL
and	NULL
T.	NULL
Brown	NULL
for	NULL
anti-GABP	NULL
antibodies	NULL
and	NULL
purified	NULL
proteins	NULL
.	NULL

*	NULL
Sheppard	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Onken	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Rosen	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Nokes	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
Adhesion	NULL
Commun	NULL
.	NULL

1	NULL
,	NULL
in	NULL
press	NULL
.	NULL

15660	NULL
REFERENCES	NULL
Austin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Kimble	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
565-571	NULL
Ben-David	NULL
,	NULL
Y.	NULL
,	NULL
Giddens	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Letwin	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Bernstein	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
908-918	NULL
Berlin	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Berg	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Briskin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Andrew	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Kilshaw	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Holzmann	NULL
,	NULL
B.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
L.	NULL
,	NULL
Hamann	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Butcher	NULL
,	NULL
E.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
185-195	NULL
Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
and	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Hybridoma	NULL
11	NULL
,	NULL
277-294	NULL
Birkenmeier	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
McQuillan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Boedeker	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
Argraves	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Ruoslahti	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
20544-20549	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
135-140	NULL
Bosselut	NULL
,	NULL
R.	NULL
,	NULL
Duvall	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Gegonne	NULL
,	NULL
A.	NULL
,	NULL
Bailly	NULL
,	NULL
M.	NULL
,	NULL
Gemar	NULL
,	NULL
A.	NULL
,	NULL
Brady	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3137-3144	NULL
Boulykos	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Pognonec	NULL
,	NULL
P.	NULL
,	NULL
Begue	NULL
,	NULL
A.	NULL
,	NULL
Galibert	NULL
,	NULL
F.	NULL
,	NULL
Gesquiere	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Stehelin	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
697-705	NULL
Briskin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McEvoy	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Butcher	NULL
,	NULL
E.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
368	NULL
,	NULL
461-464	NULL
Burtis	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Thummel	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Jones	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
and	NULL
Hogness	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
85-99	NULL
Carter	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Basu	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Avadhani	NULL
,	NULL
N.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
23418-23426	NULL
Chen	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1985	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
2993-3000	NULL
Cybulsky	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Gimbrone	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
788-791	NULL
de	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
DeLuca	NULL
,	NULL
M.	NULL
,	NULL
Helinski	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Subramani	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

4	NULL
,	NULL
725-737	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Blakeley	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Newby	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Ghazal	NULL
,	NULL
P.	NULL
,	NULL
Hennighausen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Bourgeois	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
1498-1506	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1479	NULL
Elices	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Osborn	NULL
,	NULL
L.	NULL
,	NULL
Takada	NULL
,	NULL
Y.	NULL
,	NULL
Crouse	NULL
,	NULL
C.	NULL
,	NULL
Luhowskyj	NULL
,	NULL
S.	NULL
,	NULL
Hemler	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Lobb	NULL
,	NULL
R.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
577-584	NULL
Erle	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Ruegg	NULL
,	NULL
C.	NULL
,	NULL
Sheppard	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Pytela	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
11009-11016	NULL
Feigl	NULL
,	NULL
G.	NULL
,	NULL
Gram	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Pongs	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
7167-7178	NULL
Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
Koisumi	NULL
,	NULL
S.	NULL
,	NULL
Fisher	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
and	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Hybridoma	NULL
9	NULL
,	NULL
559-571	NULL
Gegonne	NULL
,	NULL
A.	NULL
,	NULL
Leprince	NULL
,	NULL
D.	NULL
,	NULL
Duterque-Coquillaud	NULL
,	NULL
M.	NULL
,	NULL
Vandenbunder	NULL
,	NULL
B.	NULL
,	NULL
Flourens	NULL
,	NULL
A.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J.	NULL
,	NULL
Debuire	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Stehelin	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
806-812	NULL
Greenwald	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
583-590	NULL
Guan	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Hynes	NULL
,	NULL
R.	NULL
O	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
53-61	NULL
Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Bryner	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Graves	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
667-679	NULL
Gutman	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2241-2246	NULL
Hagemeier	NULL
,	NULL
C.	NULL
,	NULL
Bannister	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Cook	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kouzarides	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
1580-1584	NULL
Hemler	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
365-400	NULL
Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
Mueller	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Reddy	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
354	NULL
,	NULL
531-534	NULL
Kang	NULL
,	NULL
Y.	NULL
H.	NULL
,	NULL
and	NULL
Williams	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Anat	NULL
.	NULL

Rec	NULL
.	NULL

229	NULL
,	NULL
86-102	NULL
Kang	NULL
,	NULL
Y.	NULL
H.	NULL
,	NULL
Kedar	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
and	NULL
Maheshwari	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Histochem	NULL
.	NULL

Cytochem	NULL
.	NULL

89	NULL
,	NULL
413-423	NULL
Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
Urness	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Thummel	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Celada	NULL
,	NULL
A.	NULL
,	NULL
van	NULL
Beveren	NULL
,	NULL
C.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Graves	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1451-1453	NULL
Kidd	NULL
,	NULL
S.	NULL
,	NULL
Kelley	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1986	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
3094-3108	NULL
Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Celada	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
Bevern	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Maki	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
113-124	NULL
Koelle	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Talbot	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Segraves	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Bender	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Cherbas	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Hogness	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
59-77	NULL
Koisumi	NULL
,	NULL
S.	NULL
,	NULL
Fisher	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
Jorcyk	NULL
,	NULL
C.	NULL
,	NULL
Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Seth	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Oncogene	NULL
5	NULL
,	NULL
675-681	NULL
Laffon	NULL
,	NULL
A.	NULL
,	NULL
Garcia-Vincuna	NULL
,	NULL
R.	NULL
,	NULL
Humbria	NULL
,	NULL
A.	NULL
,	NULL
Postigo	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Corbi	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
De	NULL
Landa-zuri	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
546-552	NULL
LaMarco	NULL
,	NULL
K.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Byers	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Walton	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
Control	NULL
of	NULL
«	NULL
4	NULL
Integrin	NULL
Expression	NULL
by	NULL
the	NULL
Ets	NULL
Family	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
789-792	NULL
Lazenby	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Crouch	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
McDonald	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Kuhn	NULL
,	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
:	NULL
Dis	NULL
.	NULL

142	NULL
,	NULL
206-14	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Nabel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
5890-5897	NULL
Leung	NULL
,	NULL
S.	NULL
,	NULL
McCracken	NULL
,	NULL
S.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Miyamoto	NULL
,	NULL
N.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
989-997	NULL
Lux	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
John	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Bennett	NULL
,	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
36-42	NULL
Macarak	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Gorfien	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
MacGregor	NULL
,	NULL
R.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

139	NULL
,	NULL
517-528	NULL
Mould	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Wheldon	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Komoriya	NULL
,	NULL
A.	NULL
,	NULL
Wayner	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Yamada	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Humphries	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
4020-4024	NULL
Nelsen	NULL
,	NULL
B.	NULL
,	NULL
Tian	NULL
,	NULL
G.	NULL
,	NULL
Erman	NULL
,	NULL
B.	NULL
,	NULL
Gregoire	NULL
,	NULL
J.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
,	NULL
Graves	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
82-86	NULL
Neuhaus	NULL
,	NULL
H.	NULL
,	NULL
Hu	NULL
,	NULL
M.	NULL
C.	NULL
T.	NULL
,	NULL
Hemler	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Takada	NULL
,	NULL
Y.	NULL
,	NULL
Holzman	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
I.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

115	NULL
,	NULL
1149-1158	NULL
Osborn	NULL
,	NULL
L.	NULL
,	NULL
Hession	NULL
,	NULL
C.	NULL
,	NULL
Tizard	NULL
,	NULL
R.	NULL
,	NULL
Vassallo	NULL
,	NULL
C.	NULL
,	NULL
Luhowskyj	NULL
,	NULL
S.	NULL
,	NULL
Chi-Rosso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Lobb	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
1203-1211	NULL
Pardanaud	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Dieterlen-Lievre	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
Adhesion	NULL
Commun	NULL
.	NULL

1	NULL
,	NULL
151-160	NULL
Pettersson	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

1	NULL
,	NULL
962-972	NULL
Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
Huebner	NULL
,	NULL
K.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Ar-Rushdi	NULL
,	NULL
A.	NULL
,	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Reddy	NULL
,	NULL
E.	NULL
S.	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
66-70	NULL
Reddy	NULL
,	NULL
E.	NULL
S.	NULL
P.	NULL
,	NULL
Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
and	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
6131-6135	NULL
Rice	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Munro	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Bevilacqua	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
1369-1374	NULL
Rosen	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Birkenmeier	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4094-4098	NULL
Rosen	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Sanes	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
LaChance	NULL
,	NULL
R.	NULL
,	NULL
Cunningham	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Roman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
69	NULL
,	NULL
1107-1119	NULL
Ruegg	NULL
,	NULL
C.	NULL
,	NULL
Postigo	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Sikorski	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Butcher	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Pytela	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Erle	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

117	NULL
,	NULL
179-189	NULL
Segraves	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
and	NULL
Hogness	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
204-219	NULL
Seth	NULL
,	NULL
A.	NULL
,	NULL
Robinson	NULL
,	NULL
L.	NULL
,	NULL
Thompson	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Watson	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
and	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
1783-1790	NULL
Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
253	NULL
,	NULL
762-768	NULL
Virvasius	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
Virbasius	NULL
,	NULL
C.-M.	NULL
A.	NULL
,	NULL
and	NULL
Scarpulla	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
380-392	NULL
Walle	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Vartio	NULL
,	NULL
T.	NULL
,	NULL
Helve	NULL
,	NULL
T.	NULL
,	NULL
Virtanen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Kurki	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

31	NULL
,	NULL
535-540	NULL
Walsh	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Mermod	NULL
,	NULL
J.-J	NULL
.	NULL

,	NULL
Harinell	NULL
,	NULL
A.	NULL
,	NULL
Kay	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Warlow	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
3419-3423	NULL
Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1391-1399	NULL
Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Kaelin	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
1330-1335	NULL
Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Flores	NULL
,	NULL
P.	NULL
,	NULL
Begue	NULL
,	NULL
A.	NULL
,	NULL
Leprince	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Stehelin	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
846	NULL
,	NULL
191-193	NULL
Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Gutman	NULL
,	NULL
A.	NULL
,	NULL
Nicholson	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1127-1134	NULL
Watson	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
McWilliams	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Lapis	NULL
,	NULL
P.	NULL
,	NULL
Lautenberger	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Schweinfest	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
7862-7866	NULL
Wayner	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Garcia	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Humphries	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McDonald	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Carter	NULL
,	NULL
W.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

109	NULL
,	NULL
1321-1330	NULL
Weintraub	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
512-517	NULL
Wharton	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Johansen	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Xu	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Artevanis-Tsakonas	NULL
,	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
567-581	NULL
Yednock	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Cannon	NULL
,	NULL
C.	NULL
,	NULL
Fritz	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Sanchez-Madrid	NULL
,	NULL
R.	NULL
,	NULL
Steinman	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
856	NULL
,	NULL
63-66	NULL
Yochem	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Greenwald	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
553-563	NULL
Yochem	NULL
,	NULL
J.	NULL
,	NULL
Weston	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Greenwald	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
885	NULL
,	NULL
547-550	NULL
Yuan	NULL
,	NULL
Q.	NULL
,	NULL
Jiang	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Hollander	NULL
,	NULL
D.	NULL
,	NULL
Leung	NULL
,	NULL
E.	NULL
,	NULL
Watson	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Krissansen	NULL
,	NULL
G.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

176	NULL
,	NULL
1443-1449	NULL

